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Chapter 1 
 
1.1 Natural products for drug discovery  
 
Plants are the source of an almost uncountable numbers of natural compounds 
characterized by different chemical structures and a broad range of biological 
activities. Their structures are often only partially known and sometimes their 
synthetic pathways, mechanism of degradation and the functions in the original 
organism are unknown. Plant biodiversity with its richness and complexity 
represents the major resource of chemical diversity (Gullo et al., 2006). 
Human activity is often destructive so that the biodiversity of the ecosystems 
have been substantially stressed and threatened with the permanent loss of 
species, varieties, and groups (Clark, 1996; Shu, 1998).  
Nowadays, the research in the field of biology, chemistry, and medicine, is 
directed towards the identification and structural characterization of plant 
secondary metabolites with pharmacological activity to discover their detailed 
biosynthesis pathways and as molecular targets for the industrial production or 
the synthesis of new drugs. Secondary metabolites are compounds nor directly 
involved in the primary metabolism of the plant, such as growing and 
reproduction, nor simple catabolic products. Experimental evidence supports 
their important role in the species evolution. The long-lasting experience of 
traditional folk medicines may facilitate the identification of novel agents from 
bioactive plant constituents: most of them are products of secondary metabolic 
pathways whose biological function is often the self-defense, for instance the 
protection against herbivores and various pathogens or the growth regulation. 
Due to these physiologic functions, secondary metabolites could have an 
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application in certain therapeutic areas. Database of natural products have a great 
number of unused scaffolds and the differences between synthetic compounds 
and natural products are remarkable, especially in their structural properties 
(Gullo et al., 2006; Dobson, 2004; Rosén et al., 2009). However, natural product 
research needs long and deep experience, particularly in taxonomy, which cannot 
be built up in one day (Okuda, 2002). 
 
1.2 Natural compounds libraries 
 
Natural compounds are a good starting point for the setting up of libraries to 
test for drug discovery, not only for their complex and diversified chemical space 
but also for their ability to interact with biomolecules. It has long been 
recognized that natural-product structures have the characteristics of high 
chemical diversity, biochemical specificity and other molecular properties. They 
are also rich in chiral centers, steric complexity, aromatic system, and functional 
groups. All these properties make them favorable as lead structures for drug 
discovery (Koehn and Carter, 2005). 
On average, natural products incorporate fewer nitrogen, halogen, or sulfur 
atoms, but more oxygen atoms and are sterically more complex, with more 
bridgehead tetrahedral carbon atoms, and rings. The high “sterical complexity” is 
due to the fact that the enzymes used for biosynthesis, as well as their molecular 
targets, are inherently three-dimensional and chiral. Furthermore, nature has a 
limited palette of building blocks at its disposal, and thus has to generate novelty 
by branching out common intermediates into different scaffolds (Williams, 
2007).  
The screening of natural compounds libraries is a step to select potential lead 
compounds but it is true that some inconveniences using this strategy could 
occur. To create and to conserve a natural extract collection is very expensive 
and also it needs so much time. The choice of the plant materials is first step 
  
when it is clear the kind of compounds to isolate
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biological screening (Figure 1.1
 
 
Figure 
 
 
In both cases, when the 
fractionation and the identif
assays. Later on the compound 
 
Introduction Chapter 1 
: the plants are selected on the 
and phylogenetic features, ethnobotanitc and other 
ility to find bioactive extracts is to make a 
). 
1.1: Screening of natural compounds 
starting point is a complex extract, it is necessary the 
ication of the bioactive component through biological 
needs to be characterized.  
3 
 
  
 
Anyway, natural products are often structurally complex whereby the 
pharmacophoric group identification and the structure
not very simple (Ortho
process from natural source is usually very complex and it needs many extraction 
and chromatographic processes to provide pure compounds, usually in small 
amount, that should be characterized by nuclear magnetic resonance (NMR) and 
mass spectrometry (MS) techniques. In 
isolation from plant material and structural
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1.3 Diterpenes 
 
The terpenoids constitute the largest family of natural products and they play 
diverse functional roles in plants as hormones (gibberellins, abscisic acid), 
photosynthetic pigments (phytol, carotenoids), electron carriers (ubiquinone, 
plastoquinone), mediators of polysaccharide assembly (polyprenyl phosphates), 
and structural components of membranes (phytosterols). 
In addition to these universal physiological, metabolic, and structural 
functions, many specific terpenoid compounds (commonly in the C10, C15, and 
C20 families) serve in communication and defense, for example, as attractants for 
pollinators and seed dispersers, competitive phytoxins, antibiotics, and herbivore 
repellents and toxins. In spite of the economic significance of the terpenoids and 
their many essential functions, relatively little is known about terpenoid 
metabolism and its regulation in plants.  
Because all terpenoids are produced by a common biosynthetic pathway, 
sophisticated control mechanisms must exist to ensure the production of 
appropriate levels of these often structurally complex compounds in the proper 
metabolic, developmental, and environmental context. Pathway elucidation for 
highly functionalized terpenoid metabolites is not trivial, and determining the 
enzymology of terpenoid metabolism has proven very challenging, both because 
relatively little enzymatic machinery is dedicated to terpenoid metabolism and 
because many of the reaction types involved are unlike those of primary 
metabolism of carbohydrates, proteins, and lipids. The action of various 
prenyltransferases then generates from the precursor isopentenyl pyrophosphate 
(IPP) the higher order terpenoid building blocks, geranyl pyrophosphate (GPP; 
C10), farnesyl pyrophosphate (FPP; C15), and geranylgeranyl pyrophosphate 
(GGPP; C20). These branch point intermediates may then self-condense be 
utilized in alkylation reactions to provide prenyl side chains of a range of 
nonterpenoids (including proteins), or undergo internal addition (that is, 
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cyclization) to create the basic parent skeletons of the various terpenoid families. 
Finally, oxidation, reduction, isomerization, conjugation, or other secondary 
transformations elaborate the unique and manifold character of the terpenoids.  
Diterpenes are biosynthesized especially in plastids and an increasing number of 
diterpenoids are being found with skeletons that may arise by fragmentation of 
better known bi- and tri-cyclic systems (McGarvey and Croteau, 1995).  
Diterpenoids continue to be associated with the biological activity of various 
plant and marine extracts. The liverworts have continued to provide a wide range 
of diterpenoid skeletal type. Among the uncountable shown activities there are 
antitumor, antimicrobial, anti-inflammatory, antioxidant, larvicidal, plant and 
insect growth regulation activities (Hanson, 2005).  
In the following paragraphs some diterpene’s classes are decribed. 
 
1.3.1 Kauranes and ent-kauranes 
 
Kauranes represent an important group of tetracyclic diterpenes and their 
structures are constituted by a perhydrophenantrene unit (A, B and C rings) fused 
with a cyclopentane unit (D ring) formed by a bridge of two carbons between C-8 
and C-13. Different criteria are used for the nomenclature of the kaurane 
diterpenes, the most frequent being the inversion of the conventional description 
of stereochemistry when the name is preceded by the prefix "ent-" (Garcia et al., 
2007); (Figure 1.3). 
Kauranes and ent-kauranes are naturally occurring diterpenoids isolated from 
several families, such as Asteraceae and Lamiaceae. These compounds have 
attracted interest because of their structures and their biological activities as anti-
tumorals, anti-HIV, and antibacterials (Bruno et al., 2001). 
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Figure 1.3: Kauranes and ent-kauranes skeleton 
 
 
1.3.2 Clerodanes and neo-clerodanes 
 
The clerodane diterpenoids comprise a large class of natural products which 
have been studied more in recent years for their wide biological activities, for 
instance anti-tumor and apoptotic activity against different cell lines(Coll and 
Tandron, 2007). 
The clerodane diterpenoids belong to the group of diterpenoids with a 
rearranged labdane skeleton (ent-labdane). Sometimes substances of this type are 
called diterpenoids of the cascarillin group, ent-clerodanes, neo-clerodanes, and 
clerodanes. The name clerodanes is derived from the bitter principle isolated 
from Clerodendrum infortunatum L., clerodin I, whose structure was established 
in 1961. The clerodane diterpenoids belong to the bicyclic terpenoids derived 
from decalin. The carbon skeleton of the clerodane and neo-clerodane (ent-
clerodane) diterpenoids differs from the labdane skeleton by the position of the 
methyl groups (Nurmukhamedova and Sidyakin); (Figure 1.4). 
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Figure 1.4: Clerodane and labdane diterpenes skeleton 
 
 
1.3.3 Nagilactones 
 
Nagilactones are a kind of nor and bisnorditerpene dilactones known as 
allelochemical and cytotoxic compounds, sometimes with antibacterial, 
antifungal, antifeedant activity (Hayashi et al., 1972; Hayashi et al., 1992; Kubo 
et al., 1993; Kuo et al., 2008); the nagilactone C is the most studied compound 
(Figure 1.5). The dilactones are classified into three major subgroups in 
accordance with the structure of the B/C ring part: i) α-pyrone [8(14),9(11)-
dienolide] type; ii) 7α,8α-epoxy-9(11)-enolide type; iii) 7(8),9(11)-dienolide 
type. It should be noted that the dilactone members in each of these structural 
types show fine differences in their biological activity (Hayashi and Matsumoto, 
1982). 
 
O
O
O
O
OHHO
O
 
Figure 1.5: Nagilactone C structure 
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1.4 Interaction with biomolecules: potential biological activities 
 
Over the past years there has been a rapid escalation in the discovery of 
molecular targets that may be applied to the discovery of novel tools for the 
diagnosis, prevention, and treatment of human diseases. With the sequencing of 
the human genome, there has been an explosion in the knowledge of the protein 
products associated with the constituent genes and the discovery of molecular 
targets associated with various disease types, such as cancer, diabetes, and 
obesity. Natural products research plays a highly significant role in the drug 
discovery and development process, through the analysis of the molecular 
mechanism responsible of biological activity (Chin et al., 2006).  
Even though natural products may not have coevolved with human proteins, 
they have emerged in nature to interact with biomolecules and it should be 
considered that varied genomes, based on similar chemistry, have spread across 
the Earth and human genus shares its gene families with other organisms. The 
production of metabolites with a certain affinity of interaction with a large 
variety of proteins and biological targets is improved with the evolution. Mainly 
the great homology between structural and functional domains of proteins from 
animal, vegetable or marine world allows the interaction among each other with a 
comparable affinity (Caporale, 2002; Koehn and Carter, 2005; Zhang, 2007). 
Natural products should be able to penetrate biological barriers and make their 
way to certain cells or organs in which they will exert the effect. Thus, natural 
products are already biologically validated to reach and to bind specific proteins. 
Looking at all proteins and analyzing them for structural features, elements of 
conservatism and diversity may be found. The conservative elements are the 
domains: the parts that fold to compact secondary structures. Among the 
hundreds of thousands of human proteins, the number of distinct domains is only 
about 600 to 8000. Consequently, proteins that may seem altogether different are 
quite similar when viewed structurally, but diversity lies in the precise details 
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since similar domains may have very different amino acid sequences 
(Kirkpatrick, 2003). 
 
1.5 Target discovery strategies  
 
Especially for complex diseases, a lot of compounds are involved in the 
modulation of several targets and the exact targets of some drugs often remain 
unknown. The simplified “one molecule, one target” concept seems to be by now 
out-of date (Rix and Superti-Furga, 2009). Even if the multi-target interaction 
could also lead to harmful side effects, reducing the potency and efficiency of the 
drugs there is a possible application in multifactorial diseases (Bantscheff et al., 
2009). 
The identification of a drug interactome followed by biological assays for the 
measure of its activity against the identified target proteins, is actually one of the 
key processes in the drug development study. Several approaches carried out in 
the absence of the biological context have been developed to reach this goal even 
if gaining only a partial coverage of the full interactome. Recent developments in 
analytical methods, mainly in mass spectrometry and liquid chromatography, 
have had an important impact in the field of target discovery. In particular, mass 
spectrometry-based chemical proteomics has been emerging as a powerful tool to 
a comprehensive characterization of a drug interactome under physiological 
relevant conditions. Moreover, such method enables the analysis of the drug 
mechanism of action, in the context of a complex proteome accelerating the 
difficult process of target validation and drug discovery (Jeffery and Bogyo, 
2003). 
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1.5.1 Proteomics techniques 
 
Proteomics, as a scientific field, is defined as the study of the protein products 
of the genome, and their interactions and functions. Similarly, the proteins 
expressed at a given time in a given environment constitute a proteome. The 
techniques being developed in proteomics are applicable to all areas of drug 
discovery, from target identification, to assessment of drug efficacy, both in pre-
clinical (target selectivity) and clinical situations (patient response), to protein 
profiles for diagnostics.  
For drug discovery, the ideal proteomics method would be one that is: 
 
1. Sensitive enough to detect low-abundance proteins. 
2. Able to detect activity over in addition to abundance. 
3. Able to detect protein–protein and protein–small molecule 
interactions. 
4. Easily implemented and performed quickly (Burbaum and Tobal, 2002). 
 
Several proteomic techniques are based on two-dimensional gel-
electrophoresis, isotope-coded affinity-tagging, “drug on-beads” immobilization, 
affinity chromatography.  
 
1.5.2 Chemical proteomics 
 
A new research field is chemical proteomics, or activity-based proteomics, 
that is considered a combination of affinity purification and mass spectrometric 
identification of a set of proteins targeted (or captured) by a small molecule. It is 
a multidisciplinary technique, involving different research areas such as 
biochemistry, cell biology, organic synthesis and mass spectrometry. This 
technique allows the analysis of all potential targets of a molecule in a single 
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experiment, leading to a complete and selective target mapping of a drug 
candidate. This means that the drug is able to fish out its own targets directly 
from the biological sample of interest.  
Chemical proteomics approaches include several different experimental 
procedures, however three of them have emerged as most popular: (i) fishing for 
partners (or pull down), which employs a ligand immobilized onto a solid 
support, (ii) global proteomics, in which isobaric tags are used to asses changing 
in protein concentration upon drug treatment, and (iii) ABPP, activity-based 
protein profiling, which uses active site-directed probes to record variations in 
the activity of enzymes in a whole proteome (Sadaghiani et al., 2007; Rix et al., 
2007). 
The pull down assay is based on the non covalent and specific interactions 
occurring between the small molecule and its potential binders, and the following 
purification and mass spectrometric identification of these interacting proteins 
(Jeffery and Bogyo, 2003); (Figure 1.6). 
One of the methods includes the compound of interest (with known or 
unknown biological activity) anchoring to a solid support through a spacer arm. 
This matrix is then treated with a lysate, from cells or tissue, to promote the 
interaction between the anchored compound and its specific binding proteins. 
After several washing steps, useful to reduce the amount of non-specific binding 
proteins, the captured proteins are eluted and subjected to either Sodium Dodecyl 
Sulphate Polyacrylamide gel electrophoresis (SDS PAGE), or gel free 
chromatography. The peptide mixtures obtained after trypsin digestion are then 
submitted to MS analysis and database search for the final protein identification. 
The first step of the procedure is the drug on-beads immobilization: molecules 
containing one or more reactive sites or after synthetic modifications can be 
attached to a such solid support. To avoid or reduce steric interferences between 
the targets and the ligand-bearing matrix, the solid support is usually modified 
with an opportune spacer arm that provides a suitable distance between the beads 
  
and the small molecule. The choice of the solid support is one of the most 
important steps of the experiment
support is then added to an opportune protein extract from a cell culture, tissue or 
serum, to promote ligand protein interaction. After the treatment, the matrix is 
washed to reduce the amount of the non
elution of the retained ones is carried on. The eluted proteins are sequentially 
separated by gel electrophoresis, 
finally analyzed and identified by HPLC
There are proteins exclusively interacted with the linker or the beads, proteins 
highly abundant with low affinity for the drug
high affinity for matrix with the drug.
 
 
Figure 
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Another key step is the protein identification: one of the procedure involves 
the previous enzymatic digestion of the proteins and the tandem mass 
spectrometric analysis of the complex peptide mixtures (Chait, 2006). The usual 
proteolytic enzyme used in proteomics is trypsin, a protease that cleaves peptides 
at C-terminus of arginine and lysine residues. The peptides originated by 
proteolytic cleavage have a size less than 3 kDa and a free amino group at C-
terminus, and give rise to doubly and triply charged peptides, when exposed to a 
mass spectrometer.  
The peptide mixture is subjected to liquid chromatography coupled tandem 
MS analysis, and the raw data are processed to give a peak list submitted to a 
protein search in a data base, for instance Mascot that is a web program 
comparing the experimental MS2 spectra with theoretical fragment spectra 
generated “in silico” and needing of parameters such as peptide tolerance, 
proteolytic enzyme, miss cleavage and variable modifications (Perkins et al., 
1999). 
 
1.5.3 Target validation 
 
The results obtained by this technique are only indicative and useful to have 
an idea of the possible target of a compound but it is necessary to determine the 
biological relevance and the kind of the interaction. 
In the first case biological assays aimed to identity enzymatic inhibition, 
activity ability, in vivo and in vitro effects, etc. according to the kind of the 
identified proteins, are necessary. 
The physical interaction could be determined by measuring the quantitative 
binding parameters with different techniques like surface plasmon resonance 
(SPR), isothermic titration calorimetry (ITC), STD-NMR, and cocrystallization 
experiments. 
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1.6 Objectives of the thesis project 
 
As part of an ongoing research program on plants biosynthesizing diterpenes, 
it was performed a project aimed to create a diterpenes library from different 
plant’s species. These compounds were subjected to a chemical proteomic study 
as a strategy for the molecular target identification of natural bioactive 
compounds, setting up a method for the research of their molecular targets.  
The attention was paid on plants known to be rich on diterpenes, since they 
are a class of natural terpenoids with a great structural variability and a wide 
spectrum of biological activities.  
Particularly two diterpenes included in our library were considered: a semi 
synthetic compound 15-ketoatractyligenin methyl ester, and the hardwickiic acid.  
From an experimental point of view, this work was divided into the following 
steps: (i) isolation and structural characterization of new and known diterpenes 
through a phytochemical study in order to enrich a pre-existing diterpenes library 
with new structures (ii) chemical proteomic approach as a strategy for the 
research of the molecular target of the ent-kaurane 15-ketoatractyligenin methyl 
ester (iii) validation techniques of the protein Hsp27 as a target for the clerodane 
diterpene hardwickiic acid. 
According to the primary purpose, Podocarpus elongatus (Aiton) L’Hèr. ex 
Pers, Podocarpus gracilior Pilger (Podocarpaceae), Clerodendrum splendens G. 
Don. (Verbenaceae), and Sideritis pullulans Vent. (Lamiaceae) were selected. 
In chapters 2-4 the extraction and isolation methods and the structural 
characterization procedures of new and known compounds from the previously 
listed plants are described. 
In chapter 2 the diterpenes isolated from P. elongatus leaves are reported: the 
new diterpenes nagilactone C 7-O-α-L-arabinopyranosyl-(1→4)-β-D-
xylopyranoside, nagilactone C 7-O-β-D-glucopyranosyl-(1→4)-β-D-
xylopyranoside, nagilactone C 7-O-β-D-xylopyranoside, nagilactone A 7-O-α-L-
Introduction Chapter 1 
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arabinopyranosyl-(1→4)-β-D-xylopyranoside, 2β,15S,16,17,19-pentahydroxy-
isopimar-8(14)-ene 17-O-β-D-glucopyranoside, 2β,15R,16,17,19-pentahydroxy-
isopimar-8(14)-ene 17-O-β-D-glucopyranoside, and the known diterpenes 4-
carboxy-19-nor-totarol, nagilactone B, and nagilactone C. In this chapter the new 
diterpenes found in P. gracilior leaves, 2α,16-dihydroxy-4β-carboxy-O-β-D-
glucopyranosyl-19-nor-totarol, nagilactone K together with the known 
nagilactone B, nagilactone C, nagilactone D, and podolactone B are also 
mentioned. 
In chapter 3 2α-acetoxy-3β-(2’,3’-diacetoxy-2’-methyl)-butanoyloxy-14-
hydro-15-hydroxyclerodin, 3β,15-dihydroxy-14-hydro-clerodin, 2α,15-
dihydroxy-3β-(2’-hydroxy-3’-acetoxy-2’-methyl)-butanoyloxy-6α,18-diacetoxy-
4α,17-epoxy-clerodan-11,16-lactone, 3β,14S,15-trihydroxy-6α,18-diacetoxy-
4α,17-epoxy-clerodan-11,16-lactone, and the only known 14,15-dihydroxy-3-
epicarioptin isolated from C. splendens are described. 
In chapter 4 the new diterpenes isolated from S. pullulans, ent-1α,3α,7β,18-
tetrahydroxykaur-16-ene, ent-3α,11α,18-trihydroxy-17-norkauran-16-ene, ent-
3α,7β,18-trihydroxy-17-norkauran-16-one, ent-3α,7β-dihydroxy-18-acetyloxy-
17-norkauran-16-one, ent-3α,7β,16α,17-tetrahydroxy-18-acetyloxy-kaurane, ent-
7β,16α,17,18-tetrahydroxykaurane, and the known foliol, linearol, ent-3α,7β,17-
trihydroxy-18-acetyloxy-15α,16α-epoxykaurane are described. 
Chapters 5 and 6 are related to studies aimed to the research of the proteic 
target for small molecules through chemical proteomics techniques. 
In chapter 5 a fishing for partners study as a chemical proteomics strategy to 
identify the proteic target of 15-ketoatractyligenin methyl ester (SR2017) is 
described. SR2017 is semi-synthetic ent-kaurane synthetized at Dipartimento di 
Chimica Organica, Università di Palermo (Rosselli et al., 2007).  
This approach revealed the heat shock protein 70 (Hsp70) and 
peroxisomeproliferator-activated receptor gamma (PPARγ) as potential targets. 
To confirm results a SPR based binding assay was used.  
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In chapter 6 the study of hardwickiic acid (HAA) and its heat shock protein 
27 (Hsp27) interaction is reported. HAA is a diterpene chosen as a representative 
of the clerodane diterpenes library isolated from Salvia spp. Hsp27 was identified 
as potential target of HAA through a fishing for partner studies based on a 
chemical proteomics approach and in a previous study this was confirmed by 
SPR experiments.  
As first step to evaluate the effect of the interaction between HAA and Hsp27 
on protein structure and activity, a limited proteolysis-mass spectrometry based 
strategy was used.  
The ability of HAA to modulate the in vitro chaperone activity of Hsp27 was 
evaluated by monitoring substrates induced aggregation in the presence of 
Hsp27, with or without HAA. Finally to give a cellular significance to 
Hsp27/HAA interaction, it was explored the pro-apoptotic activity of the small 
molecule in human monocytes. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
Phytochemical study of Podocarpus elongatus (Aiton) L’Her. ex Pers 
and Podocarpus gracilior Pilger 
 
 
 
 
 
Based on:“Faiella L., et al., Phytochemistry, 2012, 76, 172-177“; “Faiella L., et al., 
Phytochemistry Letters, 2012, 5, 297-300“. 
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Chapter 2 
 
2.1 Introduction: Podocarpus genus  
 
Podocarpaceae is an ancient and  large family of mainly Southern Hemisphere 
conifers, comprising about 156 species of evergreen trees and shrubs. It is 
especially spread in tropical and subtropical forests of the Austral Hemisphere: 
New Zealand, New Caledon, and Tasmania are particularly rich of genera. The 
Podocarpaceae family shows great diversity, both morphologically and 
ecologically (Eckenwalder, 2009).  
Podocarpus species are important timber trees in their native areas. The 
timber is fine-grained, nonresinous, light, and moderately strong. Some species 
are used as ornamental trees, mostly for landscaping. The fruits of other species 
are eaten raw or cooked or used locally for jams and preserves. Other products 
obtained from this genus include dyes, tannins, and waxes. Some species of 
Podocarpus are used for cultural purposes in South Africa (Abdillahi et al, 
2010). Podocarpus spp. are also traditionally used in the native regions for the 
treatment of many diseases like fevers, asthma, coughs, cholera, arthritis, 
rheumatisms, and venereal diseases (Abdillahi et al., 2011). The presence or 
absence of different compounds can be used to relate the new and the old taxa. 
For example, flavonoids can be a useful chemotaxonomic tool in this group of 
plants, since biflavonoids of the amentoflavone and hinokiflavone groups have 
been shown to be good taxonomic markers in the great majority of Podocarpus 
(Abdillahi et al., 2010).  
Phytochemical and pharmacological studies of Podocarpus genus led to the 
isolation of a number of bioactive diterpenes, including nor- and bisnor-
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diterpenoid lactones (Park et al., 2004; Xuan et al., 1995), flavonoids (Markham 
et al., 1985), and ecdysones (Nakanishi et al., 1966). Since nor- and bis-
norditerpenes are taxonomic markers of these species, the possibilities that the 
related taxa will have similar biological activities or bioactive compounds cannot 
be overruled. The nagilactone C is the most studied. It had shown an 
antiproliferative activity against different type of cell lines such as fibrosarcoma 
and murine colon carcinoma. A study on Hela cells shows that it inhibits the 
eukaryotic proteic synthesis, but its molecular target is unknown (Chan et al., 
2004; Shrestha et al., 2001). 
Podocarpus elongatus (Aiton) L’Her. Ex Pers. and Podocarpus gracilior 
Pilger were selected for this study mainly because of the relevant presence of 
diterpenes in plants belonging to this genus.  
 
2.2 Podocarpus elongatus (Aiton) L’Her. ex Pers 
 
Podocarpus elongatus (Aiton) L’Her. ex Pers (Figure 2.1) is a tree native to 
South Africa and West Cape, also known as Cape yellowwood, yellow pine, fern 
pine, breade river yellowwood or westelike geelhout. It is mainly used as 
ornamental tree mostly for landscaping. The light-brown, soft durable, 
moderately strong, elastic, resinous, pale yellow brown wood is used for building 
houses, railway sleepers, beams, planks, rafters, and furnitures (Abdillahi et al, 
2010).  
There are only few and old previous phytochemical studies of P. elongatus 
that report the isolation of biflavones, namely amentoflavone, podocarpusflavone 
A, bilobetin, isoginkgetin (Prasad and Krishnamurty, 1976), hinokiflavone, and 
tetra-O-methyl-amentoflavone (Iqbal et al., 1982) and abietane diterpenes, such 
as totarol, 16-oxytotarol, and 16-hydroxytotarol (Taylor, 1965).  
 
 
  
Figure 2.1
2.3 Podocarpus gracilior
 
Podocarpus gracilior 
and East Africa, known as African fern p
insect attack (Kubo et al.,
reported the isolation of diterpenes such as podolactones (Hayashi 
nagilactones C, D, and F (Kubo 
Kupchan et al., 1975), phenolic diterpenoids (Cambie 
ponasterone A (Kubo et al.
and dimethylamentoflavone (Kubo 
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: Podocarpus elongates (Aiton) L’Her ex Pers 
 
 
 Pilger 
Pilger (Figure 2.2) is a conifer that grows in Central 
ine and characterized by a resistance to 
 1984). Previous phytochemical studies on P. gracilior
et al., 1980), 
et al., 1984), podolide (Bryan and Smith, 1975; 
et al., 1983), the ecdysone 
, 1984) and biflavonoids such as podocarpusflavone A 
et al., 1983; 1984). 
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2.4 Plant materials 
 
Leaves of P. elongatus
Cairo, Egypt, on May 2008,
same place on March 2010, b
Zoharia Research Garden, Cairo, Egypt). The voucher
elongatus Ait./1 and No
Herbarium Hortii Botanici Pisani, Flora Aegyptiaca, Pisa, Italy. 
 
2.5 Extraction and iso
 
Dried powdered leaves of 
were successively and separately extracted for 48 h with 
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2.2: Podocarpus gracilior Pilger 
 were collected in El Zoharia Research Garde
 while leaves of P. gracilior were collected in
oth were identified by Dr. Mamdouh Shokry (El 
 specimens (No. 15
. 15, P. gracilior Pilger/1) were deposited at the 
 
lation 
P. elongatus (800 g) and of P. gracilior (950 g) 
n-hexane, CHCl
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CHCl3–MeOH (9:1), and MeOH, by exhaustive maceration (2 l), to give 14.9, 
19.7, 27.2, and 35.2 g of the respective residues for P. elongatus and 11.5, 17.3, 
32.6, and 42.4 g of the respective residues for P.gracilior.  
The MeOH extract of P. elongatus was partitioned between n-BuOH and 
H2O, to afford a n-BuOH residue (15 g). Part of the n-BuOH fraction (6.0 g) was 
submitted to Sephadex LH-20 using MeOH as eluent to obtain seven major 
fractions (A-G) grouped by TLC. Fraction B (120 mg) was purified by RP-HPLC 
with MeOH-H2O (25:75) as eluent to give pure nagilactone C 7-O-β-D-
glucopyranosyl-(1→4)-β-D-xylopyranoside (compound 2, 1.6 mg, tR = 13 min), 
nagilactone C 7-O-α-L-arabinopyranosyl-(1→4)-β-D-xylopyranoside (compound 
1, 10.3 mg, tR = 15 min), 3,4,5-trihydroxydehydro-α-ionol 9-O-β-D-
glucopyranoside (compound 12, 2.3 mg, tR = 18 min), roseoside (compound 13, 
5.6 mg, tR = 20 min), and 1-(2,6,6-trimethyl-4-hydroxycyclohexenyl)-1-hydroxy-
buta-1-en-3-one 4-O-β-D-glucopyranoside (compound 7, 1.5 mg, tR = 24 min). 
Fraction C (244 mg) was subjected to RP-HPLC with MeOH-H2O (3.5:6.5) as 
eluent to give nagilactone A 7-O-α-L-arabinopyranosyl-(1→4)-β-D-
xylopyranoside (compound 4, 1.5 mg, tR = 13 min), linarionoside C (compound 
14, 1.8 mg, tR = 23 min), 2β,15S,16,17,19-pentahydroxy-isopimar-8(14)-ene 17-
O-β-D-glucopyranoside (compound 5, 2.0 mg, tR = 24 min), 2β,15R,16,17,19-
pentahydroxy-isopimar-8(14)-ene 17-O-β-D-glucopyranoside (compound 6, 2.3 
mg, tR = 25 min), and 20-hydroxyecdysone (compound 15, 8.6 mg, tR = 45 min). 
Fraction D (300 mg) was purified over RP-HPLC with MeOH-H2O (3:7) as 
eluent to yield pure erythro-4,7,9,9'-tetrahydroxy-3,3'-dimethoxy-8-O-4'-
oxyneolignan 9'-O-β-D-glucopyranoside (compound 16, 5.2 mg, tR = 14 min), 
threo-4,7,9,9'-tetrahydroxy-3,3'-dimethoxy-8-O-4'-oxyneolignan 9'-O-β-D-
glucopyranoside (compound 17, 6.4 mg, tR = 15 min), compound 13 (3.4 mg, tR = 
18 min), and icariside E3 (compound 18, 3.6 mg, tR = 25 min). The CHCl3-MeOH 
extract (6.0 g) was chromatographed over Sephadex LH-20 to give eight major 
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fractions (A-H) grouped by TLC, together with pure isoginkgetin (compound 19, 
120 mg) and bilobetin (compound 20, 25 mg). Fractions B (123 mg) and G (163 
mg) were separately purified by RP-HPLC with MeOH-H2O (3.5:6.5) as eluent 
to yield blumenol C glucoside (compound 21, 2.7 mg, tR = 11 min) and 
compound 13 (3.1 mg, tR = 13 min), from fraction B and vitexin 2''-O-β-D-(6'''-
acetyl)-glucopyranoside (compound 8, 14.4 mg, tR = 41 min) from fraction G, 
respectively. Fraction D (60 mg) was also purified by RP-HPLC with MeOH-
H2O (3:7) as eluent to yield nagilactone C 7-O-β-D-xylopyranoside  (compound 
3, 3.7 mg, tR = 13 min) and compound 13 (2.0 mg, tR = 18 min). Finally, fractions 
C (390 mg), E (185 mg), and F (220 mg) were separately subjected to RP-HPLC 
with MeOH-H2O (2:3) as eluent to give compounds 18 (2.3 mg, tR = 20 min) and 
15 (2.8 mg, tR = 45 min) from fraction C, nagilactone C (compound 22, 2.5 mg, 
tR = 8 min), compounds 16 (3.5 mg, tR = 9 min) and 17 (2.7 mg, tR = 10 min) 
from fraction E, and nagilactone B (compound 23, 3.0 mg, tR = 9 min) and 
glochidiobioside (compound 24, 2.0 mg, tR = 15 min) from fraction F, 
respectively. 
Part of the CHCl3 extract (10.0 g) was chromatographed over silica gel 
column eluting with CHCl3 followed by increasing concentrations of MeOH in 
CHCl3 (between 1% and 50%). Fractions of 25 ml were collected, analyzed by 
TLC (silica gel plates, in CHCl3 or mixtures of CHCl3-MeOH 99:1, 98:2, 97:3, 
9:1, 4:1), and grouped into 10 fractions (A-L). Fraction G (290 mg) was purified 
by RP-HPLC with MeOH-H2O (8.5:2.5) as eluent to obtain 4β-carboxy-19-nor-
totarol (compound 25, 3.1 mg, tR = 10 min). 
The MeOH extract of P. gracilior was partitioned between n-BuOH and H2O, 
to afford a n-BuOH residue (5 g) that was submitted to a Sephadex LH-20 using 
MeOH as eluent to obtain eight major fractions (A-H) grouped by TLC. Fraction 
B (372 mg) was purified by RP-HPLC with MeOH-H2O (2.5:7.5) as eluent to 
give15-hydroxy phaseic acid (compound 11, 1.7 mg, tR = 10 min), compound 22 
(4.0 mg, tR = 19 min), 2α,16-dihydroxy-4β-carboxy-O-β-D-glucopyranosyl-19-
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nor-totarol (compound 9, 1.6 mg, tR = 38 min), and 24 (1.2 mg, tR = 40 min). Part 
of the CHCl3-MeOH extract (10.0 g) was chromatographed over Sephadex LH-
20 to give ten major fractions (A-K) grouped by TLC. Fractions C (275 mg) and 
E (350 mg) were separately purified by RP-HPLC with MeOH-H2O (3.5:6.5) as 
eluent to yield compounds 21 (1.2 mg, tR = 36 min) and 15 (5.4 mg, tR = 38 min) 
from fraction C and compounds 22 (8.4 mg, tR = 11 min), nagilactone D 
(compound 26, 1.8 mg, tR = 17 min), 17 (3.5 mg, tR = 21 min), and 18 (2.7 mg, tR 
= 24 min) from fraction E, respectively. Fraction F (208 mg) was also purified by 
RP-HPLC with MeOH-H2O (25:65) as eluent to yield pure podolactone B 
(compound 27,
 
1.2 mg, tR = 15 min), compounds 22 (4.3 mg, tR = 19 min), 
nagilactone K (compound 10, 1.7 mg, tR = 25 min), and 26 (4.0 mg, tR = 42 min).  
Part of the CHCl3 extract (10.0 g) was chromatographed over silica gel 
column eluting with CHCl3 followed by increasing concentrations of MeOH in 
CHCl3 (between 1% and 50%). Fractions of 25 ml were collected, analyzed by 
TLC (silica gel plates, in CHCl3 or mixtures of CHCl3-MeOH 99:1, 98:2, 97:3, 
9:1, 4:1), and grouped into 13 fractions (A-M). Fractions C (363 mg), D (100 
mg) and E (182 mg) were subjected to RP-HPLC with MeOH-H2O (3.5:6.5) as 
eluent to give pure compound 26 (8.9 mg, tR = 17 min) from fraction C, 
compounds 22 (6.1 mg, tR = 10 min) and 26 (5.0 mg, tR = 17 min) from fraction 
D, and compound 23 (6.2 mg, tR = 11 min) from fraction E, respectively. The 
structures of new compounds 1-11 are showed in Figure 2.3 and Figure 2.4 
respectively. The structures of the diterpenes 22, 23, and 25 are showed in 
Figure 2.5 while 26 and 27 are reported in Figure 2.6. The structures of the other 
compounds are reported in Figure 2.7. 
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2.6 New isolated compounds 
 
Nagilactone C 7-O-α-L-arabinopyranosyl-(1→4)-β-D-xylopyranoside (1) 
 
Amorphous powder; [ ]25Dα -10 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 285 
(3.80) nm; 1H and 13C NMR, see Table 2.1; HRESIMS m/z 649.2122 [M+Na]+ 
(calcd. for C29H38O15Na, 649.2108); ESI-MS m/z 649 [M+Na]+,  517 [M+Na-
132]+, 385 [M+Na-132-132]+. 
 
Nagilactone C 7-O-β-D-glucopyranosyl-(1→4)-β-D-xylopyranoside (2) 
 
Amorphous powder; [ ]25Dα +1.6 (c 0.05, MeOH); UV (MeOH) λmax (log ε) 290 
(3.80) nm; 1H and 13C NMR, see Table 2.1; HRESIMS m/z 679.2261 [M+Na]+ 
(calcd. for C30H40O16Na, 679.2214); ESI-MS m/z 679 [M+Na]+,  517 [M+Na-
162]+, 385 [M+Na-162-132]+. 
 
Nagilactone C 7-O-β-D-xylopyranoside (3) 
 
Amorphous powder; [ ]25Dα +5 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 280 
(4.12) nm; 1H and 13C NMR, see Table 2.1; HRESIMS m/z 517.1712 [M+Na]+ 
(calcd. for C24H30O11Na, 517.1686); ESI-MS m/z 517 [M+Na]+,  385 [M+Na-
132]+. 
 
Nagilactone A 7-O-α-L-arabinopyranosyl-(1→4)-β-D-xylopyranoside (4) 
Amorphous powder; [ ]25Dα -16 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 282 
(4.08) nm; 1H and 13C NMR, see Table 2.1; HRESIMS m/z 635.2357 [M+Na]+ 
(calcd. for C29H40O14Na, 635.2316); ESI-MS m/z 635 [M+Na]+,  503 [M+Na-
132]+. 
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2β,15S,16,17,19-Pentahydroxy-isopimar-8(14)-ene 17-O-β-D-
glucopyranoside (5)  
 
Amorphous powder; [ ]25Dα +1.3 (c 0.08, MeOH); 1H and 13C NMR, see Table 
2.2; HRESIMS m/z 539.2888 [M+Na]+ (calcd. for C26H44O10Na, 539.2832); ESI-
MS m/z 515 [M-H]-,  353 [M-H-162]-, 293 [M-H-162-60]-. 
 
2β,15R,16,17,19-Pentahydroxy-isopimar-8(14)-ene 17-O-β-D-
glucopyranoside (6) 
 
Amorphous powder; [ ]25Dα +3.6 (c 0.2, MeOH); 1H and 13C NMR, see Table 
2.2; HRESIMS m/z 539.2895 [M+Na]+ (calcd. for C26H44O10Na, 539.2832); ESI-
MS m/z 515 [M-H]-,  353 [M-H-162]-. 
 
1-(2,6,6-Trimethyl-4-hydroxycyclohexenyl)-1-hydroxy-buta-1-en-3-one 4-O-
β-D-glucopyranoside (7) 
 
Amorphous powder; [ ]25Dα -42.9 (c 0.08, MeOH); UV (MeOH) λmax (log ε) 
284 (3.78) nm; 1H and 13C NMR, see Table 2.2; HRESIMS m/z 409.1870 
[M+Na]+ (calcd. for C19H30O8Na, 409.1839); ESI-MS m/z 409 [M+Na]+,  325 
[M+Na-84]+. 
 
Vitexin 2''-O-β-D-(6'''-acetyl)-glucopyranoside (8) 
 
Amorphous powder; [ ]25Dα -5 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 272 
(3.90), 335 (3.22) nm; 1H and 13C NMR, see Table 2.2; HRESIMS m/z 659.1600 
[M+Na]+ (calcd. for C29H32O16Na, 659.1588); ESI-MS m/z 659 [M+Na]+,  569 
[M+Na-90]+, 539 [M+Na-120]+, 455 [M+Na-204]+. 
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2α,16-Dihydroxy-4β-carboxy-O-β-D-glucopyranosyl-19-nor-totarol (9) 
 
Amorphous powder; [ ]25Dα  +50.2 (c 0.05, MeOH); UV (MeOH) λmax (log ε) 
230 (3.89), 278 (4.40) nm; 1H and 13C NMR, see Table 2.3; HRESIMS m/z 
511.2537 [M+H]+ (calcd. for C26H38O10, 511.2543); ESI-MS m/z 533 [M+Na]+,  
371 [M+Na-162]+. 
 
Nagilactone K (10) 
 
Amorphous powder; [ ]25Dα  +4.1 (c 0.2, MeOH); UV (MeOH) λmax (log ε) 246 
(4.03) nm; 1H and 13C NMR, see Table 2.3; HRESIMS m/z 319.1160 [M-H]- 
(calcd. for C17H20O6, 319.1182); ESI-MS m/z 319 [M-H]-,  275 [M-H-44]-. 
 
15-Hydroxy phaseic acid (11) 
 
Amorphous powder; [ ]25Dα  +2.1 (c 0.06, MeOH); UV (MeOH) λmax (log ε) 
260 (3.95) nm; 1H and 13C NMR, see Table 2.3; HRESIMS m/z 297.1320 [M-H]- 
(calcd. for C15H22O6, 297.1338); ESI-MS m/z 297 [M-H]-,  253 [M-H-44]-. 
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Figure 2.3: New isolated compounds from P. elongatus 
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Figure 2.4: New isolated compounds from P. gracilior 
 
 
 2.7 Structural elucidation 
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(9-11) together with nine known compounds, some of which are in common with 
P.elongatus. The following known compounds were identified by comparison 
with published spectroscopic data: nagilactone B (Hayashi et al., 1980), 
nagilactone C (Kubo and Ying, 1991), nagilactone D (Hayashi et al., 1980), 
podolactone B (Hayashi et al., 1980), 4β-carboxy-19-nor-totarol (Kubo and 
Ying, 1991), roseoside (Otsuka et al., 1995), blumenol C glucoside (Pabst et al., 
1992), linarionoside C (Otsuka, 1994), 3,4,5-trihydroxydehydro-α-ionol 9-O-β-
D-glucopyranoside (Rastrelli et al., 1998), icariside E3 (Kuono et al., 1991), 
erythro-4,7,9,9'-tetrahydroxy-3,3'-dimethoxy-8-O-4'-oxyneolignan 9'-O-β-D-
glucopyranoside (Matsuda and Kituchi, 1996), threo-4,7,9,9'-tetrahydroxy-3,3'-
dimethoxy-8-O-4'-oxyneolignan 9'-O-β-D-glucopyranoside (Matsuda et al., 
1996), glochidiobioside (Takeda et al., 1998), isoginkgetin (Markham et al., 
1987), bilobetin (Markham et al., 1987), and 20-hydroxyecdysone (Miller et al., 
1985). 
The molecular formula of compound 1 (C29H38O15) was established by 13C 
NMR and ESIMS (m/z 649 [M+Na]+) spectra, indicating eleven degrees of 
unsaturation. In the ESIMS spectrum of compound 1 two ion fragments at m/z 
517 [M+Na-132]+ and 385 [M+Na-132-132]+, due to the subsequent losses of 
two pentose residues, were observed. The α,β,γ-unsaturated lactone carbonyl 
functionality was evidenced by the presence of an ester carbonyl resonance at 
164.2 ppm in the 13C NMR spectrum (Table 2.1). The 1H NMR spectrum showed 
the presence of two methyls singlet at δ 1.43 (Me-18), 1.49 (Me-20), two methyl 
doublets at δ 1.25 (Me-16) and 1.38 (Me-17), five oxymethines at δ 3.43 (H-2), 
3.59 (H-1), 4.39 (H-3), 5.12 (Η−6), 5.56 (H-7), and  one singlet olefinic proton at 
δ 6.38 (H-11) (Table 2.1). COSY and 1D-TOCSY measurements showing 
couplings between H-1―H-3, H-5―H-7, H-15―H-17 led to the assignement of 
the spin systems. HMBC correlations from H-11 to C-8, C-12, C-14 confirmed 
the assignment of α,β,γ-lactone ring carbons. Furthermore the HMBC 
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correlations of H-1 signal centered at δ 3.59 with C-3, C-5, and C-10 and HMBC 
correlations of H-2 (δ 3.43) with C-4, C-10, and Me-20 established the presence 
of a 1β,2β-epoxide. The elucidation of the whole skeleton from the above 
subunits was achieved on the basis of HSQC and HMBC correlations, which also 
allowed the assignment of all the resonance in the 13C NMR spectrum of the 
pertinent carbons. By this way, the aglycon moiety of 1 was characterized as 
nagilactone C (Kubo and Ying., 1991). 1D-TOCSY, DQF-COSY, and HSQC 
experiments provided evidence for the presence in the molecule of two pentose 
residues. On the basis of chemical shifts, multiplicity, values of the coupling 
constants, and magnitude in the 1H and 13C NMR spectra, the two sugar moieties 
were characterized as one β-xylopyranose and one α-arabinopyranose (Table 
2.1) (De Tommasi et al., 1997). The HMBC experiment provided the sugar 
sequence through unambiguous correlations between H-7C-1xyl and H-1araC-
4xyl. The configuration of the sugar units was assigned after hydrolysis of 1 with 
1N HCl and GC analysis of trimethylsilyated sugars through a chiral column. 
The sugar units were so determined to be D-xylopyranose and L-arabinopyranose. 
On the basis of the above evidences, compound 1 was identified as nagilactone C 
7-O-α-L-arabinopyranosyl-(1→4)-β-D-xylopyranoside. 
The molecular formula of compound 2 (C30H40O16) was established by 13C 
NMR and ESIMS spectrum (m/z 679 for [M+Na]+). In the ESIMS spectrum were 
also observed two main fragments at m/z 517 [M+Na-162]+ and 385 [M+Na-162-
132]+) due to the subsequent loss of one hexose and one pentose. Its NMR 
spectral data (Table 2.1) suggested that the structure of 2 resembled that of 1, but 
differed in the sugar chain. Comparison of chemical shifts of 2 with those of 1 
suggested that the arabinopyranosyl residue was replaced by a β-glucopyranosyl 
unit. The absolute configuration of the sugar units was determined as reported for 
1. Thus, the structure of 2 was identified as nagilactone C 7-O-β-D-
glucopyranosyl-(1→4)-β-D-xylopyranoside. 
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The ESIMS of compound 3 (C24H30O11) showed a main signal at m/z 517 
([M+Na]+) and a fragmentation pattern similar to that of 1. Furthermore, in the 
MS2 spectrum a fragment ion peak at m/z 385 [M+Na-132]+ was detected, 
indicating the loss of one pentose unit. Analysis of the NMR data (Table 2.1) of 
compound 3 and comparison with those of 1 revealed 3 to differ from 1 only by 
the absence of the terminal arabinopyranose unit. Thus, compound 3 was 
determined as nagilactone C 7-O-β-D-xylopyranoside. 
Compound 4 was isolated as a colourless optically active amorphous powder, 
with [α]D = -16 (c = 0.1, MeOH). In the ESIMS spectrum, the [M+Na]+ signal 
was observed at m/z 635, consistent with the molecular formula C29H40O14. A 
peak at m/z 503 [M+Na-132]+ was also observed, due to the loss of one pentose 
unit. The observation of signals in the 13C NMR spectrum (Table 2.1) consistent 
with δ-lactones and the presence of 19 carbon signals for the aglycon moiety led 
to the conclusion that this compound was again a norditerpene lactone glycoside 
(Kubo and Ying, 1991). The 1H and 13C NMR data (Table 2.1) of 4 indicated the 
presence of two double bond and two hydroxyl group (δH 3.93, δC 72.0; δH 5.51, 
δC 65.0). An isopropyl group was clearly evident in the 1H NMR spectrum (two 
methyl doublets at δ 1.25 and 1.38 and a one proton signal at δ 3.40). The 
absence of further coupling of the isopropyl proton at δ 3.40 indicated C-14 was 
fully substituted. The 1H NMR spectral data combined with 1D TOCSY and 
DQF-COSY experiments suggested the sequence C-1C-3 and C-5C-7. 
Analysis of the proton coupling of the carbinolic protons allowed the remaining 
substitution pattern to be determined. Thus, the aglycon of compound 4 was 
recognized to be nagilactone A (Xuan et al., 1995). Structural elucidation of the 
sugar moiety was performed on the basis of DQF-COSY and 1D TOCSY; 
starting from the well isolated anomeric signal at δ 4.45 (d, J = 7.5 Hz), the first 
sugar spin system was clarified to be β-xylose, while from the anomeric signal at 
δ 4.37 (d, J = 7.0 Hz), the other saccharide was identified as α-arabinose. The 
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sequence of the sugar chain could be assigned by the correlations in the HMBC 
spectrum between signal at δ 5.51 (H-7) and C-1xyl (δ 100.8) and δ 4.37 (H-1ara) 
and C-4xyl (δ 77.0). The absolute configuration of the sugar units was determined 
as reported for 1. From the foregoing evidence, the structure of 4 was established 
as nagilactone A 7-O-α-L-arabinopyranosyl-(1→4)-β-D-xylopyranoside.  
The molecular formula of 5 (C26H44O10) was determined by ESIMS ([M-H]- at 
m/z 515). The 1H NMR spectrum (Table 2.2) showed signals for two tertiary 
methyl groups, two pairs of doublets centered at δ 3.05 (J = 11.0 Hz), 3.30 (J = 
11.0 Hz), 3.76, and 3.85 (J = 12.0 Hz) for two hydroxymethylene groups, signals 
for protons at δ 3.79, 3.67, and 3.47 (br d, J = 9.0 Hz), and a hexose residue. The 
1H NMR spectral data combined with 1D TOCSY and DQF-COSY experiments 
suggested the sequence C-1C-3, C-5C-7, C-9C-12, and C-15C-16. The 
13C NMR spectrum (Table 2.2) showed the presence of two hydroxymethines, 
one trisubstituted double bond, three hydroxymethylenes, and was in good 
agreement with that of a pimarane derivative (Nishiya et al., 1991; Politi et al., 
2002). Structural elucidation of the glucopyranose moiety was performed on the 
basis of 1D TOCSY; starting from the well isolated anomeric proton signal at δ 
4.28, the sugar spin system was clarified. The configuration of the glucose unit of 
5 was obtained as reported before. The 13C NMR signals were assigned on the 
basis of a HSQC experiment. Location of the hydroxyl groups, the double bond, 
and the sugar unit was obtained by analysis of the HMBC spectrum. In fact, the 
signals at δ 3.47 and 3.67 (H2-16) correlated with carbon resonances at δ 43.3 (C-
13), 75.0 (C-15), and 125.3 (C-14), the signal at δ 3.79 (H-15) correlated with a 
signal at δ 65.5 (C-16), leading to the location of one diol group at C-15 and C-
16; the signals at δ 3.76 and 3.85 (H2-17) correlated with δ 25.7 (C-12), 43.3 (C-
13), and 75.0 (C-15), establishing the location of one hydroxymethylene at C-17, 
and finally the signals at δ 3.05 and 3.30 (H2-19) correlated with δ 19.2 (Me-18), 
40.0 (C-4), 45.3 (C-3), 47.5 (C-5), positioning the third hydroxymethylene 
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function at C-19. The HMBC correlations between H-14 and C-7, C-12, and C-
16 confirmed the C-8/C-14 double bond, while correlation between δ 4.28 (H-
1glc) and 72.6 (C-17) established the sugar location. 2D ROESY measurements 
supported the proposed structure and proved the relative stereochemistry at C-2, 
C-4, C-5, C-10, and C-13. Thus, the signal of the proton at δ 0.89 (Me-20) 
correlated with H-19a (δ 3.05) and H-17b signals (δ 3.85), the proton signal at δ 
3.84 (H-2) affected the Me-18 (δ 0.85) signal, the proton signal at δ 1.44 (H-5) 
correlated with the H-9 (δ 1.90) signal, while the signal at δ 3.76 (H-17a) 
influenced H-12a (δ 1.36), H-19a (δ 3.05), and H-1glc (δ 4.28). The absolute 
configuration of the 15,16-diol moiety of 5 was determined by the circular 
dichroism (CD) induced after in-situ complexation with dimolybdenum 
tetracetate in DMSO solution (Di Bari et al., 2001). According to a rule proposed 
by Snatzke (Frelek et al., 1999), the sign of the diagnostic band at about 305 nm 
correlated with the absolute configuration of the chiral centers in the 1,2-diol 
moiety. In particular a S-monosubstituted glycol gives rise to a positive Cotton 
effect at 305 nm. Thus the positive sign observed in the CD spectrum of 5 
allowed us to assign the S-configuration to C-15. Consequently, 5 was 
characterized as 2β,15S,16,17,19-pentahydroxy-isopimar-8(14)-ene 17-O-β-D-
glucopyranoside. 
Compound 6 was assigned molecular formula C26H44O10 (ESIMS 
pseudomolecular negative ion peak at m/z 515 [M-H]-), being an isomer of 5. The 
spectral data (Table 2.2) of compound 6 indicated its diterpene skeleton. 
Comparison of its NMR spectra with those of 5 showed that 6 differed from 5 in 
the signals due to the 1,2-diol moiety and the 13C NMR resonances of C-12, C-
13, C-14, and C-17. The absolute configuration of the 15,16-diol moiety of 6 was 
determined by the same method reported for 5. The negative sign observed in the 
CD spectra of 6 led to the assignment of R-configuration to C-15. Thus, 6 was 
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identified as 2β,15R,16,17,19-pentahydroxy-isopimar-8(14)-ene 17-O-β-D-
glucopyranoside. 
The ESIMS spectrum of compound 7 showed a quasi molecular ion peak at 
m/z 409 [M+Na]+ appropriate for a molecular formula C19H30O8. The 13C NMR 
data of 7 revealed 19 carbon signals, with 6 of them ascribable to one hexose unit 
and 13 to an α-ionol aglycon (Table 2.2) (De Tommasi et al., 1996). Analysis of 
1H NMR spectrum (Table 2.2) confirmed the presence of four methyl groups (δH 
1.24, 1.30, 1.56, 2.23), one (δH 5.96) olefinic proton, and one carbinol proton (δH 
4.16). The DQF-COSY spectrum of 7 indicated for the aglycon moiety, two spin 
system corresponding to the –CH2CHOHCH2- and the -CH3COCH=COH- 
moieties, respectively. The three-proton singlet at δ 2.23 and the sharp one-
proton singlet at δ 5.96 indicated that the side chain consisted in a β-diketone 
functionality present in one of the two enolized tautomeric forms. One additional 
tetrasubstituted double bond was apparent from the 13C NMR resonances at δ 
123.7 and 124.0. A HSQC experiment established the association of the protons 
with the corresponding carbons and HMBC spectrum led to the location of the 
five remaining quaternary carbons at C-1, C-5, C-6, C-7, and C-9. Definitive 
evidence in the compound 7 structure was derived by the HMBC spectrum, 
which clearly showed cross peaks between H-8 (δ 5.96) and C-1 (δ 36.0), C-6 (δ 
124.0), C-9 (δ 202.0), and C-10 (δ 26.6); Me-10 (δ 2.23) and C-9 (δ 202.0); Me-
13 (δ 1.56) and C-3 (δ 72.7), C-4 (δ 48.0), and C-5 (δ 123.7); H-1glc (δ 4.41) and 
C-3 (δ 72.7). The 1H NMR and 13C NMR data of the sugar portion of 7 led to 
conclude that the hexose moiety was β-glucopyranose. The absolute 
configuration of the sugar units was determined as reported for 1. From all these 
data, the structure of 7 was determined as 1-(2,6,6-trimethyl-4-
hydroxycyclohexenyl)-1-hydroxy-buta-1-en-3-one 4-O-β-D-glucopyranoside. 
The aglycon of 7 was previously isolated in its β-diketone form as a metabolite 
from the dinoflagellate Prorocentrum minimum (Andersen et al., 1980).  
Phytochemical studies Chapter 2 
 
35 
 
The positive ESIMS of 8 showed an [M+Na]+ ion at m/z 659 consistent with 
the molecular formula C29H32O16. Major fragments at m/z 569 [M+Na-90]+ and 
539 [M+Na-120]+ were typical of a C-glycosylflavone (Waridel et al., 2001), 
while a fragment at m/z 455 [M+Na-204]+ indicated the loss of an acylated 
terminal sugar. The 1H NMR spectrum (Table 2.2) showed an A2B2 spin system 
at δ 6.90 (2H, d, J = 8.5 Hz) and 8.00 (2H, d, J = 8.5 Hz), together with two 
singlet at δ 6.20 and 6.71, a sugar chain [two anomeric protons at δ 4.81 (1H, d, J 
= 8.0 Hz) and δ 4.13 (1H, d, J = 7.8 Hz)], and an acetyl group at δ 1.86 (3H, s). 
Analysis of 13C NMR spectrum (Table 2.2) and a combination of 1D-TOCSY, 
DQF-COSY, and HSQC experiments suggested that 8 was a vitexin derivative 
and one β-glucopyranosyl unit was the additional sugar residue (Pauli and Junior, 
1995; Cheng et al., 2000). The exact location of the sugars and the acetyl moiety 
was revealed by the HMBC correlations observed between the anomeric proton 
signal at δH 4.81 (H-1glcI) and C-8 (δ 105.5), C-9 (δ 158.3), and C-7 (δ 164.5) and 
between the anomeric proton signal at δH 4.13 (H-1glcII) and C-2glcI (δ 80.3), and 
by the downfield shift for H2-6glcII, indicating the occurrence of acylation at C-
6glcII. Therefore the structure of 8 was determined to be vitexin 2''-O-β-D-(6'''-
acetyl)-glucopyranoside. 
The CHCl3, CHCl3-MeOH, and n-BuOH extracts of P. gracilior gave the new 
compounds 9-11. The molecular formula of compound 9 (C26H38O10) was 
established by 13C NMR and HR-MS (obsd m/z 511.2537 for [M+H]+ calcd m/z 
511.2543) indicating eight degree of unsaturation. The NMR data (Table 2.3) 
showed that six of the elements of unsaturation were present as an aromatic ring, 
a hexose residue, and an esterified carboxylic group. Therefore the molecule was 
tricyclic. In the 1H NMR spectrum of 9, two methyl singlets resonating at δ 1.13 
and 1.42 were assigned as C-20 and C-18, respectively. One methyl doublet at δ 
1.33 (J = 6.5 Hz, Me-17) was also present. DQF-COSY and 1D TOCSY 
measurement showing coupling between H-1H-3, H-5H-7, H-15H-17 
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allowed assignment of these spin systems. Likewise, a HMBC correlation to the 
Me-17 resonance established the C-16 hydroxymethylene function at δ 66.0. The 
hydroxymethine resonance at δC 65.3 and δH 4.27 (1H, m) was assigned to C-2 
by HMBC cross peaks between H-2 and C-1, Me-20 and C-1, C-2, and C-5, H2-3 
and C-1, C-5, C-18, and C-19, H-1b and C-2, C-5, and Me-20. The NMR 
chemical shifts in comparison to related compounds showed the presence of a 
carboxylic group at C-4 (δC 177.3). The aromatic region of the 1H NMR 
spectrum showed two ortho-coupled doublets at δ 6.59 (J = 8.0 Hz) and 7.03 (J = 
8.0 Hz) that were assigned to H-12 and H-11, respectively. Both these protons 
showed HMBC correlations with C-8, C-9, and C-14. The presence of a 
hydroxyisopropyl group was assumed from diagnostic signals of Me-17 (δ 1.33, 
d, J = 6.5 Hz), H-15 (δ 3.30, m) and H2-16 (δ 3.91, 2H, m). According to HMBC 
spectrum the hydroxymethilene protons at δ 3.91 (H2-16) showed a long range 
correlation with H-14 and Me-17, while the methine proton at δ 3.30 (H-15) 
exhibited a long range correlation with C-8 and C-13 signals, indicating a 19-
nor-totarol derivative (Kubo and Ying, 1991). The relative stereochemistry of 
compound 9 was obtained on the basis of 2D-ROESY data. The α-orientation of 
hydroxyl group at C-2 was indicated by ROE cross peak among proton spatially 
related H-2 with Me-20. This was confirmed by chemical shifts of the respective 
carbons which matched well with those of related diterpenes (Braca et al., 2004). 
1D-TOCSY, DQF-COSY, and HSQC experiments provided evidence for the 
presence in the molecule of one hexose residue. On the basis of chemical shifts, 
multiplicity, values of the coupling constants, and magnitude in the 1H and 13C 
NMR spectra, the sugar moiety was characterized as one β-glucopyranose. Its 
configuration was assigned after hydrolysis of 9 with 1N HCl and GC analysis of 
trimethylsilylated sugar through a chiral column. The sugar unit was so 
determined to be D-glucopyranose. The HMBC correlation between δ 5.50 (H-
1glc) and 177.3 (C-19) established the sugar location. Hence, compound 9 was 
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concluded to be 2α,16-dihydroxy-4β-carboxy-O-β-D-glucopyranosyl-19-nor-
totarol. 
In the ESI-MS spectrum of 10 an ion at m/z 319 [M-H]- and a prominent 
fragment due to the loss of CO2 (m/z 275 [M-H-44]-) were observed. Thus, the 
molecular formula of 10 was C17H20O6, which required a rearranged diterpenoid 
skeleton (HR-MS m/z 319.1160, calcd for 319.1182). The 17 carbon signals in 
the 13C NMR spectrum (Table 2.3) were established as three methyls, two 
methylenes, six methines, of which five were oxygenated, two quaternary 
carbons, two sp2 carbons, and two lactone groups. Three spin systems were 
recognized from 1D TOCSY and DQF-COSY spectra: H-1H-3, H-5H-7, H-
14H-16. In the 1H NMR spectrum (Table 1) two protons at δ 4.08 (d, J = 5.0 
Hz) and 3.39 (dd, J = 9.0, 4.5 Hz), correlating in the HSQC spectrum with two 
signals at 56.4 and 50.8 ppm, respectively, allowed to establish the presence of 
an epoxy ring which was located at C-1/C-2 on the basis of the HMBC 
experiment. Key correlation peaks between H-1C-20, H-1C-10, H-2C-1, 
H-3C-1, H-3C-5, H-3C-19 were observed. In the 1H NMR the signal at δ 
5.02 (br d, J = 5.0 Hz) was attributed to an equatorial H-6. NMR data of H-6 and 
C-6 and HMBC correlations between H-6C-10, H-6C-8, H-6C-4 and H-
5C-19, H-5C-7, H-5C9, and H-5C-10 led to establish the presence of a 
6,19-olide ring. The signals at δ
 
172.2 was assigned to C-11 of a 14,11-olide ring 
by its HMBC correlations with the signals of H-7 and H-14. The DQF-COSY 
spectrum revealed that H-15 was coupled with H-14 which indicated that the 
isoethyl group of 10 was adjacent to a methine carbon not a sp2 carbon as in the 
case of nagilactone C (Hayashi et al., 1980) demonstrating that the C-ring was 
not an α-pyrone. The ROESY indicated that the protons at position 1, 2, and 3 
and 5 and 6 were syn, relative to each other. On the basis of our spectroscopic 
data, the ring C resulted a five-membered α,β-unsaturated γ-lactone. From these 
results, the structure of compound 10 was determined and named nagilactone K. 
Phytochemical studies Chapter 2 
 
38 
 
The five-membered norditerpene dilactones are very rare in nature (Fang et al., 
1990; Kubo and Ying, 1991). 
The composition of compound 11 was determined by HR-MS spectrometry 
(m/z 297.1320 [M-H]-) and 13C NMR analysis as C15H22O6. The 1H and 13C NMR 
(Table 2.3) spectra indicated that 11  was a sesquiterpenoid derivative. The 
carbon signals of 11  were sorted by HSQC and 13C NMR into two methyls, two 
methylenes, one hydroxymethine, two hydroxymethylenes, three quaternary 
carbons, two of which were hydrxoylated, four olefinic carbons, and one 
carboxylic group. With phaseic acid used as a reference compound in the spectral 
analysis of 11, close similarities were observed between spectral data of both 
compound ring, while their side chain provided the point of difference (Zhang et 
al., 2010). The main differences were the absence of the signal ascribable to the 
methyl group linked to sp2 C-9 and the presence of an additional 
hydroxymethylene group at δH 4.40 (1H, s) and δC 63.3 that was located at C-9 
by HMBC correlations. Thus, 11 was determined as 15-hydroxy phaseic acid.  
The present investigation of P. elongatus and P. gracilior substantiates that 
norditerpene lactones, biflavones, and C-glycosylflavones are characteristic 
constituents of the genus Podocarpus and could be used as chemotaxonomic 
markers (Abdillahi et al., 2010, 2011; Markham et al., 1985). 
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Figure 2.5: Structure of known diterpenes isolated from P. elongatus: compounds 22 
and 23 were isolated also from P. gracilior 
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Figure 2.6: Structure of the other known diterpenes isolated from P. gracilior 
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Figure 2.7: Structure of the other known compounds 
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Table 2.1:1H and 13C NMR data of compounds 1-4 (CD3OD, 600 MHz)a 
 1  2  3 4   
position δH δC δH δC δH δC δH δC 
1 3.59 d (5.5) 59.0 3.60 d (5.5) 58.0 3.62 d (5.5) 59.5 3.93 dd (11.0, 5.5) 72.0 
2a 3.43 dd (6.0, 5.5) 51.8 3.48 dd (6.0, 5.5) 52.0 3.40 dd (6.0, 5.5) 52.1 1.73 m 29.8 
2b       1.98 m  
3 4.39 d (6.2) 68.4 4.42 d (6.0) 67.8 4.42 d (6.2) 68.8 1.55 m 28.2 
4  50.1  49.5  50.3 2.27 ddd (12.0. 10.0, 4.5) 43.8 
5 2.13 d (6.7) 51.6 2.14 d (6.5) 51.0 2.16 d (6.7) 51.3 1.89 d (6.5) 50.8 
6 5.12 dd (6.0, 2.0) 73.6 5.14 dd (6.0, 2.0) 72.0 5.13 dd (6.5, 2.0) 73.5 5.21 dd (6.5, 2.0) 74.5 
7 5.56 d (9.0) 64.7 5.57 d (9.0) 64.2 5.60 d (9.0) 64.8 5.51 d (9.0) 65.0 
8  109.4  109.5  109.0  109.6 
9  167.2  167.0  167.1  168.0 
10  38.9  38.6  38.6  42.4 
11 6.38 s 108.3 6.40 s 108.0 6.42 s 108.4 6.78 s 108.0 
12  164.2  164.0  163.9  165.0 
14  172.3  172.1  171.6  171.8 
15 3.39 b 30.3 3.38 b 30.3 3.40 b 30.3 3.40 b 30.9 
16 1.25 d (6.6) 21.7 1.28 d (6.5) 21.2 1.29 d (6.7) 21.9 1.25 d (6.7) 21.3 
17 1.38 d (6.8) 20.3 1.41 d (6.6) 20.4 1.42 d (6.7) 20.7 1.38 d (6.7) 20.4 
18 1.43 s 26.0 1.45 s 25.4 1.46 s 25.8 1.33 s 24.4 
19  179.8  179.5  179.3  183.3 
20 1.49 s 18.2 1.51 s 17.9 1.52 s 18.5 1.44 s 15.0 
Xyl 1 4.43 d (7.5) 100.0 4.41 d (7.5) 100.7 4.38 d (7.5) 100.4 4.45 d (7.5) 100.8 
2 3.34 dd (9.0, 7.5) 73.8 3.35 dd (9.0, 7.5) 73.5 3.29 dd (9.0, 7.5) 74.5 3.38 dd (9.0, 7.5)  73.6 
3 3.51 t (9.0) 74.5 3.50 t (9.0) 75.4 3.33 t (9.0) 77.5 3.51 t (9.0) 75.0 
4 3.74 m  77.5 3.78 m  77.8 3.57 m 70.8 3.93 m 77.0 
5a 3.45 dd (12.0, 4.5) 64.0 3.43 dd (12.0, 4.5) 63.7 3.30 b 66.4 3.44 dd (12.0, 5.0) 63.8 
5b 4.11 dd (12.0, 2.5)   4.17 dd (12.0, 3.0)   4.02 dd (12.0, 5.0)  4.15 dd (12.0, 3.0)  
Ara 1 4.34 d (7.0) 103.7     4.37 d (7.0) 103.5 
2 3.59 dd (9.0, 7.0) 71.8     3.59 dd (9.0, 7.0) 71.6 
3 3.50 dd (9.0, 2.5) 75.2     3.55 dd (9.0, 2.5) 74.0 
4 3.83 m 69.6     3.84 m 69.0 
5a 3.59 dd (12.0, 3.0) 67.1     3.62 dd (12.0, 3.0) 67.0 
5b 3.91 dd (12.0, 2.0)      3.91 dd (12.0, 2.0)  
Glc 1   4.44 d (7.5) 102.9     
2   3.24 dd (9.2, 7.5) 74.5     
3   3.28 t (9.2) 77.3     
4   3.30 t (9.2) 70.8     
5   3.41 m 77.5     
6a   3.68 dd (12.0, 5.0) 62.8     
6b   3.88 dd (12.0, 3.0)      
 
a
 J values are in parentheses and reported in Hz; chemical shifts are given in ppm; assignments 
were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments. 
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Table 2.2: 1H and 13C NMR data of compounds 5-8  (CD3OD, 600 MHz)a 
 5  6   7  8  
position δH δC δH δC position δH δC δH δC 
1a 1.00 t (11.0) 48.7 1.00 t (11.0) 48.7 1  36.0   
1b 2.01 br d (11.0)  2.01 br d (11.0)  2a 1.58 dd (14.0, 8.0) 45.0  165.0 
2 3.84 m 65.6 3.84 m 65.3 2b 2.00 dd (14.0, 4.5)    
3a 1.46 t (11.0)  45.3 1.46 t (11.0) 45.1 3 4.16 m 72.7 6.71 s 102.2 
3b 1.60 br d (12.0)  1.60 t (12.5)  4a 1.78 m 48.0  184.0 
4  40.0 - 40.2 4b 2.17 dd (13.0, 5.0)    
5 1.44 b 47.5 1.44 b 47.4 5  123.7  162.4 
6a 1.30 m 22.8 1.30 m 22.6 6  124.0 6.20 s 97.8 
6b 1.54 m  1.54 m  7  177.0  164.5 
7a 2.17 m 36.6 2.17 m 36.2 8 5.96 s 102.0  105.5 
7b 2.31 br d (11.0)  2.31 br d (11.0)  9  202.0  158.3 
8  139.6 - 139.6 10 2.23 s 26.6  105.8 
9 1.90 dd (9.0, 2.0) 52.3 1.90 dd (9.0, 2.0) 52.2 11 1.30 s 29.6   
10  39.8  39.9 12 1.24 s 32.9   
11a 1.55 m 19.4 1.55 m 19.4 13 1.56 s 30.6   
11b 1.67 m  1.67 m  1'    123.4 
12a 1.36 m 25.7 1.36 m 24.8 2'/6'   8.00 d (8.5) 129.0 
12b 1.72 m  1.72 m  3'/5'   6.90 d (8.5) 115.8 
13  43.3  43.3 4'    162.2 
14 5.30 s 125.3 5.30 s 124.6 GlcI 1 4.41 d (7.5) 102.5 4.81 d (8.0) 71.4 
15 3.79 b 75.0 3.79 br t (6.0) 77.5 2 3.16 dd (9.5, 7.5) 74.7 4.08 dd (9.0, 7.5) 80.3 
16a  3.47 br d (9.0) 65.5 3.47 br d (10.0) 66.8 3 3.35 t (9.5) 77.4 3.53 t (9.0) 78.5 
16b 3.67 b  3.67 b  4 3.32 t (9.5) 71.4 3.49 t (9.0) 70.2 
17a 3.76 b 72.6 3.54 d (12.0) 73.1 5 3.35 m 77.4 3.25 m 81.6 
17b 3.85 d (12.0)  4.07 d (12.0)  6a 3.67 dd (12.0, 5.0) 62.5 3.54 dd (12.0, 5.0) 61.2 
18 0.85 s 19.2 0.85 s 19.4 6b 3.86 dd (12.0, 3.0)  3.76 dd (12.0, 3.0)  
19a 3.05 d (11.0) 71.5 3.05 d (10.5) 71.4 GlcII 1   4.13 d (7.8) 104.1 
19b 3.30 d (11.0)  3.30 d (10.5)  2   2.77 b 73.0 c 
20 0.89 s 16.7 0.89 s 16.7 3   2.92 t (9.5) 75.9 
Glc 1 4.28 d (7.8) 104.2 4.30 d (7.5) 104.8 4   2.85 dd (4.0, 2.5) 68.9 
2 3.22 dd (9.0, 7.8) 75.0 3.21 dd (9.0, 7.5) 75.0 5   2.77 b 74.1 c 
3 3.38 t (9.0) 77.6 3.38 t (9.0) 77.8 6b   3.55 dd (12.0, 4.5) 63.5 
4 3.29 t (9.0) 71.0 3.30 t (9.0) 71.3 6b   3.77 dd (12.0, 2.5)  
5 3.29 m 77.8 3.38 m 77.7 COCH3    172.3 
6a 3.69 dd (12.0, 5.0) 62.5 3.68 dd (12.0, 4.5) 62.5 COCH3   1.86 s 20.3 
6b 3.90 dd (12.0, 3.5)  3.86 dd (12.0, 3.0)       
 
a
 J values are in parentheses and reported in Hz; chemical shifts are given in ppm; assignments 
were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments. 
b overlapped signal  
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Table 2.3: 1H and 13C NMR data of compounds 9-11
 
(CD3OD, 600 MHz)a 
 
a
 J values are in parentheses and reported in Hz; chemical shifts are given in ppm; assignments 
were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments. 
b overlapped signal  
 
 9  10   11 
position δH δC δH δC δH δC 
1a 1.20 t (12.5) 49.7 4.08 d (5.0) 56.4  48.4 
1b 2.57 dd (12.5, 4.0)      
2a 4.27 m 65.3 3.39 dd (9.0, 4.5) 
50.8 
1.67 br d (12.5) 44.6 
2b     1.87 m  
3a 1.11 t (13.0) 46.8 4.42 d (7.0) 69.7 4.11 m 65.0 
3b 2.56 dd (12.5, 4.0)      
4a  45.2  48.8 1.74 dd (12.0, 3.0) 46.0 
4b     2.02 dd (14.5, 7.0)  
5 1.51 br d (12.5) 53.0 2.07 d (6.0) 54.4  87.0 
6a 2.04 m 22.1 5.02 br d (5.0) 74.7  83.0 
6b 2.32 dd (12.5, 4.0)      
7a 2.64 m 30.9 2.77 br d (19.0) 27.2 6.42 d (16.0) 131.2 
7b 3.10 dd (17.0, 5.0)  3.23 dd (19.0, 9.0)    
8  135.6  165.2 7.73 d (16.0) 129.6 
9  140.3  135.7  149.1 
10  40.6  34.8 6.05 br s 120.8 
11 7.03 d (8.0) 125.2  172.2  170.5 
12a 6.59 d (8.0) 115.3   3.71 d (7.5) 77.4 
12b     3.81 d (7.5)  
13     0.95 s 16.3 
14  128.3 4.98 m 84.7 1.16 s 19.7 
15a 3.30 m 36.8 1.66 m 26.0 4.40 s 63.3 
15b   2.04 m    
16 3.91 m 66.0 0.99 t (7.0)  8.4   
17 1.33 d (6.5) 15.2     
18 1.42 s 28.7 1.49 s 26.0   
19  177.3  180.0   
20 1.13 s 24.9 1.07 s 17.0   
Glc 1 5.50 d (7.5) 95.5     
2 3.41 dd (9.0, 7.5) 73.8     
3 3.38 t (9.0) 78.7     
4 3.39 t (9.0) 70.1     
5 3.43 m 78.0     
6a 3.70 dd (12.0, 4.5) 62.1     
6b 3.92 dd (12.0, 3.0)      
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
Phytochemical study of Clerodendrum splendens G. Don. 
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Chapter 3 
 
3.1 Introduction: Clerodendrum genus 
 
The genus Clerodendrum L., Verbenaceae family, is very widely distributed 
in tropical and subtropical regions of the world and is comprised of small trees, 
shrubs, and herbs (Figure 3.1).The Latin name used since from the beginning is 
“Clerodendrum” while the Greek form is “Clerodendron” in Greek “Klero” 
means chance and “Dendron” means tree. Later it was readopted the Latinized 
name “Clerodendrum”, which is now commonly used by taxonomists for the 
classification and description of the genus and species (Moldenke 1985; Rueda 
1993; Hsiao and Lin, 1995; Steane et al., 1999).  
Clerodendrum is a very large and diverse genus; till now 580 species have 
been identified and are widely distributed in Asia, Australia, Africa, and 
America. Many species of the genus have also been documented in traditional 
systems of medicine practiced in countries like India, China, Korea, Thailand, 
and Japan. Ethno-medical importance of various species of this genus has been 
reported in many indigenous systems of medicines and as folk medicines. Anti-
inflammatory, antidiabetic, antimalarial, antiviral, antihypertensive, 
hypolipidemic, and antioxidant activities are among the major reported. It was 
also known the tribal use of C. inerme as an antidote of poisoning from fish, 
crabs, and toads.  
 
  
Figure 3.1: 
Constituents of Clerodendrum 
sesquiterpenes, diterpenes, triterpene
of the major source of 
naturally occurring compounds with interesting biological activities isolated 
mainly from Asteraceae, La
2007). 
 
3.2 Clerodendrum splendens
 
Clerodendrum splendens 
attractive red flowers (Figure 3.2
used in traditional Nigerian medicine. 
the treatment of skin diseases, cancer, syphilis, gonorrhea, ulcers, and various 
inflammatory diseases (Okwu
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Flowers of Clerodendrum spp. 
 
 
genus are mainly terpenes: monoterpenes, 
s, and iridoids. Clerodendrum genus is one 
neo-clerodane diterpenoids that are a large group o
miaceae, and Verbenaceae (Shrivastava and Patel
 
G. Don is a climbing evergreen brush plant 
) native to Sierra Leone (West Africa) and is 
The roots and leaves decotion are used
 and Uchenna, 2009).  
 
45 
f 
, 
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Figure 3.2: 
 
 
3.3 Plant material 
 
Leaves of C. splendens
Cairo, Egypt, on March 2010 and identified by Dr. Mamdouh Shokry (El Zoharia 
Research Garden, Cairo, Egypt). The voucher specimen (No. 7191 
G. Don /1) was deposited at the Herbarium Hortii Botan
Aegyptiaca, Pisa, Italy.  
 
3.4 Extraction and isolation
 
Dried powdered leaves of 
separately extracted for 48 h with 
MeOH, by exhaustive maceration (2 l), to give 
respective residues. 
The MeOH extract was partitioned  between 
BuOH residue (5.7 g). The 
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Clerodendrum splendens leaves  
and flowers 
 were collected in El Zoharia Research Garden of 
C. splendens 
ici Pisani, Flora 
 
C. splendens (775 g) were successively and 
n-hexane, CHCl3, CHCl3–MeOH (9:1), and 
15.6, 13.5, 21.7, 26.8 g of  the 
n-BuOH and H2O, to afford a 
n-BuOH fraction was submitted to a Sephadex LH
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using MeOH as eluent to obtain twelve major fractions (A-N) grouped by TLC. 
Fraction B (1.041 g) was partitioned between n-BuOH and H2O, to afford a n-
BuOH  residue (780 mg) that was purified by RP-HPLC with MeOH–H2O (2:3) 
as eluent to give pure phlinoside B (compound 6, 9 mg, tR =13 min), the new 
compound, β-(3,4-dihydroxyphenyl)ethyl-O-β-D-xylopyranosyl-(1→2)-α-L-
rhamnopyranosyl-(1→3)-6-O-t-caffeoyl-β-D-glucopyranoside (compound 1, 1.1 
mg, tR=20 min) and hispidulin-7-O-neohesperoside (compound 8, 1 mg, tR = 38 
min). Fraction E (248.2 mg), fraction G (76.7 mg) and fraction I (115 mg) were 
directly subjected to RP-HPLC with MeOH–H2O (2:3) as eluent to give pure 
compound 1 (5.6 mg), 8 (7.4 mg) and verbascoside (compound 9, 2.4 mg, tR =13 
min) from fraction E, isoacteoside (compound 10, 5.1 mg, tR =20 min) from G 
and. hispidulin-7-O-β-D-glucopyranoside (compound 7, 2 mg, tR=45 min) and 
luteolin-7-neohesperoside, (compound 11, 2.2 mg, tR =29 min) from I. Fraction N 
(120 mg) was purified by RP-HPLC with MeOH–H2O ( 35:65) as eluent to give 
pure rosmarinic acid (compound 12, 6.6 mg , tR = 35 min). Part of the CHCl3–
MeOH extract (10 g) was chromatographed over Sephadex LH-20 to give twelve 
major fractions (A-N) grouped by TLC. Fractions F (188.5 mg) was purified by 
RP-HPLC with MeOH–H2O (35:65) as eluent to yield compound 6 (11.9 mg, tR = 
22 min). Fraction H (70 mg) was also purified by RP-HPLC with MeOH–H2O 
(2:3) as eluent to yield compound 7 (8.6 mg, tR = 38 min). Part of the CHCl3 
extract  (10.0 g) was chromatographed over silica gel column eluting with CHCl3 
followed by increasing concentrations of MeOH in CHCl3 (between 1% and 
50%). Fractions were grouped by TLC into 17 fractions (A-S). Fraction H-L 
(1.552 g) was purified by RP-HPLC with MeOH–H2O (7:3) as eluent to yield 2β-
angeloyloxy-5β-hydroxy-7α,10β-methyl-eudesm-3-ene-1-one (compound 13, 1.5 
mg, tR = 19 min). Fraction O (500 mg) was purified by RP-HPLC with MeOH–
H2O (3:2) as eluent to yield 14,15-dihydro-15-hydroxy-3-epicarioptin (compound 
14, 5.5 mg, tR = 11 min) and the new compound 2α-acetoxy-3β-(2’,3’-diacetoxy-
2’-methyl)-butanoyloxy-14-hydro-15-hydroxyclerodin (compound 2, 5.4 mg, tR 
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= 22 min). Fractions Q (292 mg) and S (270 mg) were purified by RP-HPLC 
with MeOH–H2O (2:3) as eluent to yield the new 3β,15-dihydroxy-
14hydroclerodin (compound 3, 1.8 mg, tR = 27 min) from fraction Q and the new 
compound 3β,14S,15-trihydroxy-6α,18-diacetoxy-4α,17-epoxy-clerodan-11,16-
lactone (compound 5, 10.3 mg, tR = 12 min) from fraction S. Fraction R (294 mg) 
was purified by RP-HPLC with MeOH–H2O (45:55) as eluent to yield the new 
compound 4, 2α,15-dihydroxy-3β-(2’-hydroxy-2’-methyl-3’-acetoxy)-
butanoyloxy-6α,18-diacetoxy-4α,17-epoxy-clerodan-11,16-lactone (compound 
4, 1.4 mg, tR = 20 min). New compounds 1-5 are showed in Figure 3.3 and 3.4. 
Compounds 6-14 are reported in Figure 3.5 and 3.6. 
 
3.5 New isolated compounds 
 
β-(3,4-dihydroxyphenyl)ethyl-O-β-D-xylopyranosyl-(1→2)-α-L-
rhamnopyranosyl-(1→3)-6-O-t-caffeoyl-β-D-glucopyranoside (1) 
 
Brown amorphous powder; [ ]25Dα  -10.7 (c 0.5, MeOH); UV (MeOH) λmax (log 
ε) 220sh (3.88), 288sh 3.95), 330 (4.09) nm; HRESIMS m/z 757.2637 [M+H]+ 
(calcd. for C34H44O19, 757.2555); ESI-MS m/z 755 [M-H]-,623 [M-H-132]-, 593 
[M-H-162]-; 779, m/z 779 [M+Na]+, 647 [M+Na-132]+, 501 [M+Na-146]+;1H and 
13C NMR data, see Table 3.1 
 
2α-acetoxy-3β-(2’,3’-diacetoxy-2’-methyl)-butanoyloxy-14-hydro-15-
hydroxyclerodin (2) 
 
Colorless amorphous powder; [ ]25Dα -9.4 (c 0.45, MeOH); HR-ESIMS [M+H]+ 
727.3204 (calcd. for C35H51O16, 727.3177); ESI-MS m/z 749 [M+Na]+, 689 
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[M+Na-60]+, 531 [M+Na-218]+, 489 [M+Na-218-42]+, 471 [M+Na-218-60]+, 
411 [M+Na-218-60-60]+. 1H and 13C NMR data, see Table 3.2. 
 
3β,15-dihydroxy-14hydro-clerodin (3) 
 
Colorless amorphous powder; [ ]25Dα  +5.7 (c 0.15 MeOH); HRESIMS m/z 
469.2500 [M+H]+ (calcd for C24H37O9, 469.2438); ESI-MS m/z 467 [M-H]-, 425 
[M-H-42]-, 383 [M-H-42-42]-; 491 [M+Na]+, 431 [M+Na-60]+., 371 [M+Na-60-
60]+. 1H and 13C NMR data, see Table 3.2. 
 
2α,15-dihydroxy-3β-(2’-hydroxy-2’-methyl-3’-acetoxy-)-butanoyloxy-6α,18-
diacetoxy-4α,17-epoxy-clerodan-11,16-lactone (4) 
 
Colorless amorphous powder; [ ]25Dα  -5.7 (c 0.11, MeOH); HR-ESIMS m/z 
[M+H]+ 643.2899 (Calcld. for C31H47O14, 643.2966); ESI-MS m/z 665 [M+Na]+, 
605 [M+Na-60]+, 486 [M+Na-176]+. 1H and 13C NMR data, see Table 3.3. 
 
3β,14S,15-trihydroxy-6α,18-diacetoxy-4α,17-epoxy-clerodan-11,16-lactone 
(5) 
Colorless amorphous powder; [ ]25Dα  +2.6 (c 0.13, MeOH); HR-ESIMS m/z 
485.2423 [M+H]+, 507.2246 [M+Na]+ (calcd. for C24H37O10, 485.2387, 
C24H36O10Na, 507.2206); ESI-MS m/z 507 [M+Na]+, 447 [M+Na-60]+, 
387[M+Na-60-60]+. 1H and 13C NMR data, see Table 3.3. 
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Figure 3.3: Structure of compound 1 
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Figure 3.4: Structures of new diterpenes isolated from C. splendens leaves 
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3.5 Structural elucidation  
 
Compound 1 molecular formula was determined as C34H44O19 by high-
resolution electrospray ionization (HR-ESI) mass spectrometry (m/z 757.2637 
[M+H]+). Its ESIMS spectrum showed a quasimolecular ion peak at m/z 779 
[M+Na]+; two main fragments at m/z 647 [M+Na-132]+ and 501 [M+Na-132-
146]+ due to the loss of one pentose and one deoxyhexose moiety were also 
observed. The 13C NMR spectrum (Table 3.1) of 1 displayed 34 signals, of 
which 17 were assigned to the aglycone moiety, including two aromatic rings and 
one hydroxyethyl group; the remaining 17 signals corresponded to two hexoses 
and one pentose sugar residues. The 1H NMR spectrum (Table 3.1) of 1 
displayed proton signals characteristic of a t-caffeoyl group [three aromatic 
protons resonating at δ 6.80 (1H, d, J = 8.0 Hz), 6.90 (1H, dd, J = 8.0, 2.0 Hz), 
7.05 (1H, d, J = 2.0 Hz) as an ABX system and two trans olefinic protons as an 
AB system at δ 6.30, 7.58 (1H, d, J = 16.0 Hz) ] and 3,4-dihydroxyphenylethanol 
moiety [three aromatic protons at δ 6.56 (1H, dd, J = 8.0, 2.0 Hz), 6.64 (1H, d, J 
= 2.0 Hz), 6.70 (1H, d, J = 8.0 Hz) as an ABX system and an A2B2 system 
assigned to a hydroxyethyl group at δ 2.78 (2H, m), 3.76 (1H, m), 3.96 (1H, m)] 
(Karioti et al. 2003). Additionally, three signals assignable to anomeric protons 
indicated the presence of three sugar moieties: a doublet at δ 4.36 (1H, J = 7.8 
Hz, H-1 of glucose), a broad singlet at δ 5.45 (1H, J = 1.8 Hz, H-1 of rhamnose) 
and one doublet at δ 4.34 (1H, J = 7.5 Hz, H-1 of xylose), consistent with the 
following C-1 configuration: β for glucose, α for rhamnose, and β for xylose. 
These findings matched those in the HSQC/13C NMR spectra, where three 
corresponding anomeric carbons resonated at δ 104.1, 101.6, and 107.3, 
respectively. Other remaining 1H and 13C NMR signals were assigned with the 
aid of 2D NMR spectra including 1D-TOCSY, DQF-COSY, HSQC, and HMBC 
spectra. The downfield shift of C-3’ (83.8 ppm) of glucose indicated that this 
position was a glycosylation site. This finding was further confirmed by HMBC 
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experiments, where a crosspeak between H-1rha (δ 5.45) and C-3glc (83.8 ppm) 
was observed. The carbon resonances assigned to the β-xylose unit revealed no 
unusual chemical shifts, suggesting its terminal position. A further site of 
connectivity was proved to be C-2 of rhamnose, on the basis of 1H and 13C NMR 
spectra, as well as HMBC correlations between H-1xyl (δ 4.34) and C-2rha (82.3 
ppm). The acylation site was on C-6 of glucose as evidenced by the strong 
deshielding of H-6aglc and H-6bglc at δ 4.36 and 4.52 and the crosspeak between 
H-6aglc and H-6bglc and COO at 169.0 ppm. The configuration of the sugar units 
was assigned after hydrolysis of 1 with 1N HCl and GC analysis of 
trimethylsilyated sugar through a chiral column. On the basis of these data, 
compound 1 was determined to be the new phenylpropanoid glycoside β-(3,4-
dihydroxyphenyl)ethyl-O-β-D-xylopranosyl-(1→2)-α-L-rhamnopyranosyl-
(1→3)-6-O-t-caffeoyl-β-D-glucopyranoside.  
Compound 2 molecular formula was determined as C35H50O16 from its 
HRESIMS (m/z 727.3204 [M+H]+) and 13C NMR data. The ESIMS spectrum of 
2 showed a quasimolecular ion peak at m/z 749 [M+Na]+ and peaks at m/z 689 
[M+Na-60]+, 531 [M+Na-218]+, 471 [M+Na-218-60]+ and 411 [M+Na-218-60-
60]+ due to the loss of two acetyl groups and an esterified acyl group. The 1H and 
13C NMR spectra (Table 3.2) revealed the existance of five acetoxy signals, a 
methine doublet (δ 1.20, d, J = 6.5 Hz) coupled with a methyne quartet (δ 5.10, 
q, J = 6.5 Hz), and a methyl singlet (δ 1.58) arisen from a 2,3-diacetoxy-2-
methylbutanoyloxy moiety, together with the characteristic signals of a neo-
clerodane diterpene having a 4α,17-oxirane bicycle [δH 2.63, 2.91 (H2-17), δC 
41.8 (C-17); δC 64.0 (C-4)]. Analysis of 2D NMR spectra showed that compound 
2 possessed a hexahydrofurofuran ring moiety typical of 14-hydroclerodin (Ohno 
et al., 1996). In fact, protons H-11, H-15, and H-16 appeared as a pair of signals: 
H-11α δ 4.04 and 4.65 (dd, J = 11.0, 6.2 Hz, 0.5 H each); H-15 δ 5.33 and 5.45 
(br d, J = 5.7 Hz, 0.5 H each), and H-16 δ 5.61 and 5.65 (d, J = 5.2, 4.3 Hz, 0.5 H 
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each). The 13C NMR spectrum of 2 was in complete agreement with the proposed 
structure and with the previously reported 13C NMR data of other neo-clerodane 
diterpenes isolated from the genus Clerodendrum containing the same C-11/C-16 
moiety (Pandey et al., 2005). The elucidation of the whole skeleton was achieved 
on the basis of 1D-TOCSY, DQF-COSY, HSQC, and HMBC correlations, which 
also allowed the assignment of all the resonances in the 13C NMR spectrum of 
the pertinent carbons. HMBC correlations from H-1 to C-2, C-5 and C-10, from 
H-3 to C-4 and C-17, from H-16 to C-11, C-13, and C-15, from H-12 to C-13, C-
14, and C-16, from H-18 to C-4, C-5, C-6, and C-10, confirmed the assignment 
of the neo-clerodane  ring carbons. The peak correlating signals at δ 5.46 (H-3) 
and 169.2 ppm and δ 4.90 (H-2) and 172.2 ppm showed that an acetoxy group 
and 2,3-diacetoxy-2-methylbutanoyloxy function were attached at C-2 and C-3, 
respectively. Elucidation of the relative stereochemistry of 2 was mostly based on 
the close similarities of its NMR data to those of similar compounds (Pandey et 
al., 2005; Jannet et al., 1999). Thus, compound 2 was assigned as a mixture of C-
15 epimers of 2α-acetoxy-3β-(2’,3’-diacetoxy-2’-methyl)-butanoyloxy-14-
hydro-15-hydroxyclerodin.  
The molecular formula of compound 3 (C24H36O9) was established by 13C 
NMR and HRESIMS spectrum (m/z 469.2500 for [M+H]+). In the ESIMS 
spectrum two main fragments at m/z 425 [M-H-42]- and 383 [M-H-42-42]- due to 
the loss of two acetyl groups, were also observed. Its NMR spectral data (Table 
3.2) suggested that the structure of 3 resembled that of 2, but differed in the A 
ring substitutions. The observed differences in the NMR spectra of 3 and 2 were 
consistent with the presence in 3 of a hydroxyl group linked at C-3 instead of 2,3-
diacetoxy-2-methyl-butanoyloxy group and one acetoxy group at C-2 in 2. Thus, 
the structure of 3 was deduced to be a mixture of C-15 epimers of 3β,15-
dihydroxy-14-hydroclerodin.  
Compound 4 (C31H46O14) showed a quasimolecular ion peak at m/z 643.2899 
[M+H]+ in the positive HRESIMS. The prominent fragment ion observed in the 
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ESIMS spectrum at m/z 486 [M+Na-176]+ suggested the presence of a 2’-
hydroxy-3’-acetoxy-2’-methylbutanoyl moiety in 4. Analysis of the 1H and 13C 
NMR spectra (Table 3.3) of 4 clearly indicated that it also belonged to the neo-
clerodane diterpenoid class. Furthermore, by direct comparison of the NMR 
spectra of 4 with those of neo-clerodane derivatives isolated from Clerodendrum 
genus it was obvious that the compounds contained common functionalities. The 
1H NMR spectrum showed signals due to one tertiary methyl (δ 1.02, 3H, s), one 
secondary methyl (δ 0.93, 3H, J = 6.0 Hz), three acetate residues (δ 1.91. 1.99, 
and 2.11, each 3H, s), and a methyl doublet (δ 1.27, d, J = 6.5 Hz) coupled with a 
methine quartet (δ 5.12, q, J = 6.5 Hz) and a methyl singlet (δ 1.29, s) arising 
from the 2’-hydroxy-3’-acetoxy-2’-methylbutanoyloxy moiety in the C-3β 
position. It also showed the two AB quartets, typical of a primary carbinol 
methylene group at δ 4.51 and 4.65 (2H, J = 12.0 Hz each, H-18), an epoxide 
methylene group at δ 2.64 and 2.90 (2H, J = 4.0 Hz each, H-17), a doublet of 
doublets at δ 4.82 (1H, J = 11.0, 4.5 Hz, H-6) due to a C-6 proton, a multiplet at 
δ 3.64 (1H, m, H-2), and a doublet at δ 5.15 (1H, J = 6.6, H-3) due to C-3 proton. 
Signals at δ 1.80 (1H, m, H-14 a), 1.95 (1H, m, H-14b), 2.06 (1H, m, H-12a), 
2.37 (1H, m, H-12b), 2.86 (1H, m, H-13), 3.67 (1H, m, H-15a), 3.72 (1H, m, H-
14b) indicated the presence of a β-substituent carrying a five membered lactone 
ring. The structure of compound 4 was further confirmed by its 13C NMR 
spectrum. A lowfield 13C NMR resonance at 181.0 ppm suggested the presence 
of an 11,16-lactone. Besides the spectrum contained signals at δ 13.8 and 16.2 
due to the C-19 and C-20 methyl groups, respectively. Signals attributable to the 
three acetate groups appeared at δ 171.5, 171.7, 172.6, and at δ 21.2 (2 signals 
overlapped) and 21.3, where the signals due to carbons bearing the acetate groups 
appeared at δ 62.5 (C-18) and 72.2 (C-6). The carbon involved in the oxirane 
ring formation resonated at δ 43.2 (C-17) and 64.0 (C-4). Other significant 
signals were observed at δ 34.3 (C-14), 39.9 (C-13), and 60.0 (C-15). The 
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elucidation of the whole skeleton from the above subunits was achieved on the 
basis of 1D-TOCSY, DQF-COSY, HSQC, and HMBC correlations, which also 
allowed the assignment of all the resonances in the 13C NMR spectrum. The 
11,16-lactone ring was confirmed by HMBC correlations between H-12, H-13, 
and H-14 and C-16. Consequently, 4 was characterized as 2α,15-dihydroxy-3β-
(2’-hydroxy-2’-methyl-3’-acetoxy)-butanoyloxy-6α,18-diacetoxy-4α,17-epoxy-
clerodan-11,16-lactone. 
The HRESIMS of 5 showed a quasimolecular ion [M+H]+ at m/z 485.2423, 
consistent with a molecular formula of C24H36O10. In the ESIMS spectrum two 
fragments at m/z 447 [M+Na-60]+ and 387 [M+Na-60-60]+ indicated the loss of 
two acetoxy residues. The NMR data of 5 (Table 3.3) were similar to those of 4 
differing in the values of A ring and values of H-13/C-13, H-14/C-14, H-15/C-15 
(2.90/45.0 in 5 vs 2.86/39.9 in 4, 4.06/72.6 in 5 vs 1.95, 1.89/34.3 in 4, 3.49, 
3.60/64.9 in 5 vs 3.67, 3.72/60.0 in 4, respectively). The observed differences in 
the NMR spectra of 5 and 4 were consistent with the presence in 5 of a hydroxyl 
group linked at C-3 instead of 2-hydroxy-3-acetoxy-2-methyl-butanoyloxy group 
and one acetoxy group at C-2 in 4. Another difference was the presence in 5 of a 
14,15-diol moiety. The absolute configuration of the 14,15-diol moiety of 5 was 
determined by the circular dichroism (CD) induced after in-situ complexation 
with dimolybdenum tetracetate in DMSO solution (Di Bari et al., 2001). 
According to a rule proposed by Snatzke (Frelek et al., 1999), the sign of the 
diagnostic band at about 305 nm correlated with the absolute configuration of the 
chiral centers in the 1,2-diol moiety. In particular an S-monosubstituted glycol 
gives rise to a positive Cotton effect at 305 nm, while a negative sign led to the 
assignment of R-configuration. Thus the 305 nm sign observed in the CD 
spectrum of 5 allowed us to assign the S-configuration to C-14. Thus, compound 
5 was assigned the structure of 3β,14S,15-trihydroxy-6α,18-diacetoxy-4α,17-
epoxy-clerodan-11,16-lactone. 
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Figure 3.5: Structure of a known diterpene isolated from C. splendens 
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Figure 3.6: Structures of known compounds  
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Table 3.1: 1H and 13C NMR data of compound 1 (CD3OD, 600 MHz)a 
1 
Position δH δC 
1 Aglicone  130.5 
2 6.64 d (2.0) 115.9 
3  146.2 
4  145.0 
5 6.70 d (8.0) 116.8 
6 6.56 dd (8.0, 2.0) 121.2 
β  2.78 m 36.3 
α a 3.76 m 72.1 
α b 3.96 m  
1’ Glc 4.36 d (7.8) 104.1 
2’ 3.55 dd (9.0, 7.8) 74.8 
3’ 3.50 t (9.0) 83.8 
4’ 3.45 t (9.0) 70.5 
5’ 3.28 m 75.0 
6’ a 4.52 dd (12.0, 3.0) 64.4 
6’ b  4.36 dd (12.0, 4.5)  
1’’ Rha 5.45 d (1.8) 101.6 
2’’ 3.99 dd (3.0, 1.8) 82.3 
3’’ 3.77 dd (9.0, 3.0) 72.1 
4’’ 3.38 t (9.0) 74.0 
5’’ 3.98 m 69.7 
6’’ 1.24 d (6.5) 17.7 
1’’’ Xyl 4.36 d (7.5) 107.3 
2’’’ 3.38 dd (9.0, 7.5) 74.5 
3’’’ 3.90 t (9.0) 77.8 
4’’’ 3.47 m 70.5 
5’’’ a 3.22 dd (12.0, 4.5) 67.0 
5’’’ b 3.86 dd (12.0,3.0)  
1’’’’ Caffeic acid  127.8 
2’’’’ 7.05 d (2.0) 115.0 
3’’’’  149.7 
4’’’’  145.6 
5’’’’ 6.80 d (8.0) 116.4 
6’’’’ 6.90 dd (8.0, 2.0) 123.2 
α’ 6.30 (16.0) 114.7 
β’ 7.58 (16.0) 147.5 
OCO  169.0 
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Table 3.2: 1H and 13C NMR data of compounds 2 and 3 (CD3OD, 600 MHz)a 
2 3 
Position δH δC δH δC 
1 a 2.75 m 28.0 1.75 m 21.1 
1 b 1.85 m  2.28 m  
2 a  4.90b 71.6 1.30 m 31.3 
2 b   1.82 m  
3 5.46 d (10.5) 68.3 3.98 m 65.4 
4  64.0  68.0 
5  47.0  49.4 
6 4.87 dd (11.0, 4.5) 72.0 4.80 dd (11.0, 4.5) 71.7 
7 a 1.60 m 32.4 1.70 m 33.0 
7 b 1.92 m  1.42 m  
8 1.55 m 37.0 1.54 m 36.8 
9  41.6  42.0 
10 1.92 m 43.0 1.78 47.6 
11 4.65 dd (11.0, 6.2) 84, 85.1 4.63 dd (11.0, 6.0) 84.6, 84.7 
 4.04 dd (12.0, 5.0)  3.99 dd (12.0, 5.0)  
12 a 1.70 m 33.7 1.61 m 32.8 
12 b 1.48 m  2.06 m  
13 3.11 m 41.0 2.97 m 40.2 
14 a 2.26 m 40.6 2.07 m 49.7 
14 b 1.78 m  1.78 m  
15 5.45 br d (5.7), 5.33br d (3.0) 99.3, 99.6 5.45 br d (5.0), 5.54 br d 
(4.6) 
97.09, 98.5 
16 5.61 d (5.2), 5.65 d (4.3) 108.2, 109.8 5.71 d (4.7), 5.67 d (6.2) 106.8, 108.7 
17 a 2.63 (4.0) 41.8 2.84 d (3.5) 41.6 
17 b 2.91 (4.0)  2.72 d (3.5)  
18 a 4.52 d (12.3) 62.7 4.91 d (12.5) 61.6 
18 b 4.82 d (12.3)  4.33 d (12.5)  
19 0.96 s 15.0 0.92 d (6.5) 13.0 
20 0.94 d 15.2 0.95 s 15.9 
OCOCH3 2.10, 2.10, 1.97 s 21.3, 21.3, 20.3 2.10, 1.93 s 19.7, 20.2 
OCOCH3  172.2, 171.8, 170.0  172.8, 171.2 
1’  169.2   
2’  83.5   
3’ 5.10 q (6.5) 73.0   
4’ 1.20 d (6.5) 15.0   
5’ 1.58 s 15.2   
COCH3 2.10, 1.92 s 21.3, 21.2   
COCH3  171.9   
OCOCH3  172.2, 171.8, 170.0   
Phytochemical studies Chapter 3 
 
59 
 
Table 3.3: 1H and 13C NMR data of compounds 4-5 (CD3OD, 600 MHz)a 
a
 J values for Tables 3.1, 3.2, and 3.3 are in parentheses and reported in Hz; chemical shifts are 
given in ppm; assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC 
experiments. 
b
 overlapped signal 
 
4 5 
Position δH δC δH δC 
1 a 1.83 m 32.0 1.85 m 22.7 
1 b 2.19 m    
2a  3.64 m 71.0 1.40 m 34.3 
2b   2.12 br dd (11.5, 4.5)  
3 5.15 d (6.6) 74.4 4.02 dd (11.5, 5.43) 66.3 
4  64.0  68.4 
5  47.2  47.9 
6 4.82 dd (11.6, 4.5) 72.2 4.84 t (9.0) 73.0 
7 a 1.70 m 33.7 1.75 m 34.3 
7 b 1.50 m  1.50 m  
8 1.67 m 35.6 1.65 m  35.5 
9  42.5  48.0 
10 1.95 dd 43.1 1.92 dd 43.1 
11 4.70 t (9.0) 89.9 4.72 t (9.0) 88.5 
12 a 2.37 br dd (13.0, 9.0) 28.4 2.31 m 23.0 
12 b 2.06 m - 2.22 m  
13 2.86 m 39.9 2.90 m 45.0 
14 a 1.80 m 49.7 4.06 m 72.6 
14 b 1.95 m 34.3   
15 a 3.72 m 60.0 3.49 dd (7.2, 12.0) 64.9 
15 b 3.67 m  3.60 dd (6.2, 11.2)  
16  181.0  181.0 
17 a 2.64 d (3.5) 43.2 2.75 d (4.5) 43.2 
17 b 2.90 d (3.5)  2.90 d (4.5)   
18 a 4.51 d (11.5) 62.5 4.36 d (12.0) 62.8 
18 b 4.65  4.94 d (12.0)  
19 1.02 s 13.8 1.03 s  14.0 
20 0.93 d (6.0) 16.2 0.96 d (6.6) 16.4 
OCOCH3 2.11, 1.99 s 21.3, 21.2 2.12, 1.96 s 21.2, 21.4 
OCOCH3  172.6, 171.5  172.7, 171.4 
1’  172.0   
2’  77.9   
3’ 5.12 q (6.5) 75.0   
4’ 1.27 d (6.5) 13.6   
5’ 1.29 s 22.0   
OCOCH3’ 1.91 s 21.2   
OCOCH3’  171.7   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
Phytochemical study of Sideritis pullulans Vent. 
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Chapter 4 
 
4.1 Introduction: Sideritis genus 
 
The genus Sideritis belongs to Lamiaceae family and comprises more than 
150 species widely distributed in temperate and tropical regions of the Northern 
Hemisphere. Most species are mainly found in the Mediterranean area, together 
with Canary and Madeira islands. It is a genus characterized by a high number of 
hybridizations between species. The genus name derives from the Greek word 
“sideros” in reference to the use given for these plants since ancient times to heal 
wounds by weapons made with this metal (Gonzàlez-Burgos et al., 2011). The 
Sideritis species are widely used in the treatment of gastrointestinal disorders, 
rheumatism, cough, and they are commonly used as herbal tea in folk medicine 
in Mediterranean country (Guvenc et al., 2010).  
The aerial parts of plants from the genus, known as ‘mountain tea’, are used in 
popular folk medicine for gastrointestinal disorders such as stomache ache, 
indigestion, flautolence, to alleviate the symptoms of common colds and for tonic 
and diuretic effects (Erkan et al., 2011). Moreover, some compounds isolated 
from Sideritis spp. have shown antiproliferative, anti-HIV or antifeedant 
activities. Anti-inflammatory, antioxidant, antiulcerogenic, antimicrobial, 
antiherpetical activities are also reported for extracts of Sideritis spp. Moreover, 
it is known that diterpenoids isolated from this genus are responsible of 
antifeedant, antimicrobial, and anti-inflammatory activities (Gonzàlez-Burgos et 
al., 2011). 
 
 
  
 
4.2 Sideritis pullulans 
 
Sideritis pullulans Vent.
yellowish and coriaceous 
dense glandular hairs (Al
“ironwort”. Previously, only the
showing a moderate antifungal activity against some phytopathogenic fungi
(Abou-Jawdah et al., 2004).
reported. 
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 (Figure 4.1) is a perennial herb of 50-80 cm with 
floral leaves. The upper part is endowed with short 
-Eisawi, 1982). The common name of this plant is 
 composition of the essential oil was studied
 To date no phytochemical study on S. pullulans 
 
Figure 4.1: Sideritis pullulans Vent. 
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4.3 Plant material 
 
Aerial parts and roots of S. pullulans were collected in As-Salt Rocky 
mountains, Jordan, during the flowering stage in June 2009. The plant was 
identified by Dr. Ammar Bader. The voucher specimen (No. Jo-It 2009/2) was 
deposited at the Herbarium of the Pharmacognosy Laboratory, Umm Al-Qura 
University, Makkah, Saudi Arabia. 
 
4.4 Extraction and isolation 
 
Dried powdered leaves (500 g) and roots (400 g) of S. pullulans were 
successively and separately extracted for 48 h with n-hexane, CHCl3, CHCl3–
MeOH (9:1), and MeOH, by exhaustive maceration (2 l), to give 5.6, 7.2, 8.9, 
and 26.9 g of the respective residues for the leaves and 0.8, 1.0, 8.0, and 49.5 g of 
the respective residues for the roots.  
Part of the aerial parts CHCl3 extract (7 g) was chromatographed over silica 
gel column using an Isolera® Biotage® flash purification system, eluting with 
CHCl3 followed by increasing concentrations of MeOH in CHCl3 (between 1% 
and 50%). Fractions of 25 ml were collected, analyzed by TLC (silica gel plates, 
in CHCl3 or mixtures of CHCl3-MeOH 99:1, 98:2, 97:3, 9:1, 4:1), and grouped 
into 10 fractions (A-L). Fraction B (149 mg) was purified by RP-HPLC with 
MeOH-H2O (5.5:4.5) as eluent to obtain the new diterpene, 3α,7β-dihydroxy-18-
acetyloxy-17-norkauran-16-one (compound 4, 1.1 mg, tR = 15 min). Fractions D 
(125.7 mg) and H were purified by RP-HPLC with MeOH-H2O (3:2) as eluent to 
obtain the known diterpenes ent-3α,7β,17-trihydroxy-18-acetyloxy-15α,16α-
epoxykaurane (compound 9, 1.2 mg, tR = 10 min) and foliol or ent-3α,7β,18-
trihydroxy-kauran-16-ene (compound 10, 1.9 mg, tR = 65.3 min) from fraction D 
and the new compounds ent-1α,3α,7β,18-tetrahydroxy-kauran-16-ene (compound 
1, 1.2 mg, tR = 18 min) and ent-7β,16α,17,18-tetrahydroxykaurane (compound 6, 
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1.9 mg, tR = 10 min) from fraction H. Fraction E (230.9 mg), purified by RP-
HPLC with MeOH-H2O (6.5:3.5) as eluent, gave the new diterpene ent-
3α,11α,18-trihydroxykauran-16-ene (compound 2, 1.2 mg, tR = 21 min) and 
compound 10 (15 mg, tR = 35 min). Fractions F (125.7 mg), G (152.8 mg) and I 
(83.5 mg) were purified by RP-HPLC with MeOH-H2O (4.5:5.5) as eluent to 
obtain syringaresinol 4’-O-β-D-glucopyranoside (compound 11, 1.7 mg, tR = 10 
min), the new ent-3α,7β,18-trihydroxy-17-norkauran-16-one (compound 3, 1.8 
mg, tR = 22 min) and compound 9 (1.4 mg, tR = 24 min) from fraction F, 
compound 11 (4.6 mg) and the new ent-3α,7β,16α,17-tetrahydroxy-18-acetyloxy-
kaurane (compound 5, 4.6 mg, tR = 19 min) from fraction G and the iridoid 6-O-
acetylmioporoside (compound 12, 4.2 mg, tR = 24 min) from fraction I. Fraction 
L (86.4 mg), purified by RP-HPLC with MeOH-H2O (7:3) as eluent, gave the 
diterpene linearol or ent-3α,7β-dihydroxy-18-acetyloxy-kauran-16-ene 
(compound 13, 3.5 mg, tR = 24 min). 
Part of the CHCl3-MeOH extract (6.0 g) of the roots was chromatographed 
over Sephadex LH-20 to give eight major fractions (A-H) grouped by TLC. 
Fraction B (975 mg) was partitioned between n-BuOH and H2O and the n-
butanol portion (827 mg) was submitted to silica gel chromatography using an 
Isolera® Biotage® flash purification system and obtaining two major fractions 
(B1-B2). Fraction B1 (92.5 mg) was purified by RP-HPLC with MeOH-H2O 
(3.3:6.7) as eluent to give di-O-methylcrenatin (compound 14, 2.8 mg, tR = 7 
min) and 1-hydroxy-syringaresinol-1-β-D-glucopyranoside (compound 15, 1.8 
mg; tR = 19 min). Fraction B2 (101.7 mg) was purified by RP-HPLC with MeOH-
H2O (4.5:5.5) as eluent to give leonoside A or stachyoside C (compound 16, 3.8 
mg, tR = 11 min) and the new phenylpropanoid β-(3-methoxy-4-hydroxyphenyl)-
ethyl-O-α-L-arabinopyranosyl-(1→2)-L-rhamnopyranosyl-(1→3)-6-O-feruloyl-
β-D-glucopyranoside (compound 7, 3.9 mg, tR = 30 min). Fraction D (260 mg) 
was partitioned between n-BuOH and H2O and the n-butanol portion (200 mg) 
was submitted to silica gel chromatography using an Isolera® Biotage® flash 
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purification system and obtaining two major fraction (D1-D2). Fraction D 2 (25.7 
mg), purified by RP-HPLC with MeOH-H2O (2:3) as eluent, gave the new 
phenylpropanoid β-(3,4-dihydroxyphenyl)-ethyl-O-α-L-arabinopyranosyl-(1→2)-
L-rhamnopyranosyl-(1→3)-6-O-feruloyl-β-D-glucopyranoside (compound 8, 3.4 
mg, tR = 30 min). Fraction F (272.8 mg) was purified by RP-HPLC with MeOH-
H2O (5.5:4.5) as eluent to obtain the following flavonoids isoscutellarein-7-[6'''-
O-acetyl-β-D-allopyranosyl (1→2)]-β-D-glucopyranoside (compound 17, 31 mg, 
tR = 12 min), 4-methoxy-isoscutellarein-7-[6'''-O-acetyl-β-D-allopyranosyl-
(1→2)]-β-D-glucopyranoside (compound 18, 4.6 mg, tR = 23 min) and 
isoscutellarein-7-[6'''-O-acetyl-β-D-allopyranosyl-(1→2)]-6''-O-acetyl-β-D-
glucopyranoside (compound 19, 2.9 mg, tR = 29 min). Fraction H (170.6 mg), 
purified by RP-HPLC with MeOH-H2O (5.5:4.5) as eluent, gave isoacteoside 
(compound 20, 3.4 mg, tR = 30 min) and apigenin-7-O-[6'''-O-acetyl-β-D-
allopyranosyl-(1→2)]-β-D-glucopyranoside (compound 21, 3.4 mg, tR = 30 min). 
 
4.5 New isolated compounds 
 
ent-1α,3α,7β,18-tetrahydroxy-kauran-16-ene (1) 
 
Amorphous powder; [ ]25Dα  -9 (c 0.1, MeOH); HRESIMS m/z 359.3084 (calcd. 
for C20H32O4Na, 359.2198); ESI-MS m/z 359 [M+Na] +; 1H and 13C NMR, see 
Tables 4.1 and 4.3. 
 
ent-3α,11α,18-trihydroxy-17-norkauran-16-ene (2) 
 
Amorphous powder; [ ]25Dα -25.3 (c 0.1, MeOH); HRESIMS m/z 343.2141 
(calcd. for C20H32O2Na, 343.2249 ); ESI-MS m/z 319 [M-H]-; 1H and 13C NMR, 
see Tables 4.1 and 4.3. 
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ent-3α,7β,18-trihydroxy-17-norkauran-16-one (3) 
 
Amorphous powder; [ ]25Dα  -22.3 (c 0.1, MeOH); HRESIMS m/z 345.2029 
(calcd. for C19H30O4Na,. 345.2042); ESI-MS m/z 345 [M+Na] +; 1H and 13C 
NMR, see Tables 4.1 and 4.3. 
 
3α,7β-dihydroxy-18-acetyloxy-17-norkauran-16-one (4) 
 
Amorphous powder; [ ]25Dα  -23.3 (c 0.1, MeOH); HRESIMS m/z 387.2180 
(calcd. for C21H32O5Na, 387.2147), ESI-MS m/z 387 [M + Na] +; 1H and 13C 
NMR, see Tables 4.2 and 4.3.  
 
ent-3α,7β,16α,17-terahydroxy-18-acetyloxy-kaurane (5) 
 
Amorphous powder; [ ]25Dα  -22 (c 0.1, MeOH); HRESIMS m/z 419.5332 
(calcd. for C22H36O6Na , 419.2410), ESI-MS m/z 419 [M + Na] +; 1H and 13C 
NMR, see Tables 4.2 and 4.3. 
 
ent-7β,16α,17,18-tetrahydroxykaurane (6) 
Amorphous powder; [ ]25Dα  +16.6 (c 0.1, MeOH); HRESIMS m/z 361.2896 
(calcd. for C20H34O2Na, 361.2355); ESI-MS m/z 337 [M - H]-; 1H and 13C NMR, 
see Tables 4.2 and 4.3.  
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β-(3-methoxy-4-hydroxyphenyl)-ethyl-O-α-L-arabinopyranosyl-(1→2)-L-
rhamnospyranosyl-(1→3)-6-O-feruloyl-β-D-glucopyranoside (7) 
 
Amorphous powder; [ ]25Dα  -21 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 240 
(3.95), 300sh (3.88), 329 (4.10) nm; HRESIMS m/z 807.2660 (calcd. for 
C36H48O19Na, 807.2687); ESI-MS m/z 807 [M+Na]+, 675 [M+Na-132]+, 529 
[M+Na-132-146]+;1H and 13C NMR, see Table 4.4. 
 
β-(3,4-dihydroxyphenyl)-ethyl-O-α-L-arabinopyranosyl-(1→2)-L-
rhamnopyranosyl-(1→3)-6-O-feruloyl-β-D-glucopyranoside (8) 
 
Amorphous powder; [ ]25Dα  -26 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 239 
(3.85), 330 (4.01) nm; HRESIMS m/z 793.4194 (calcd. for C35H46O19Na, 
793.2531); ESI-MS m/z 793 [M+Na] +, 661 [M+Na-132] +, 515 [M+Na-132-
146]+; 1H and 13C NMR, see Table 4.4.  
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Figure 4.2: Structures of new diterpenes isolated from S. pullulans  
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Figure 4.3: Structures of compounds 7 and 8 
 
 
4.6 Structural elucidation 
 
Compound 1 showed a molecular ion peak at m/z 359.3084 [M+Na]+ in the 
HRESIMS. The resulting molecular formula was determined to be C20H32O4 
showing five degrees of unsaturation. The 13C NMR spectrum (Table 4.3) 
confirmed the presence of twenty carbons consisting of two methyls, seven 
methylenes one of which hybridized sp2, one hydroxymethylene, three methynes, 
three hydroxymethynes, and four quaternary carbons. The 13C NMR signals at δC 
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80.0, 71.4, 77.6 and 67.6 indicated the presence of four distinct oxygenated 
carbons. The signals at δC 67.2 belonged to a hydroxymethylene group. The 
HMBC spectrum demonstrated a correlation between δC 67.6 and Me-19 at δ 
0.72 and H-5 at δ 1.80, thus the position of the primary hydroxyl group was 
verified to be at C-18. In the HSQC experiment the methyne signals at δ 77.6 
correlated with the proton signals at δ 3.53 (1H, t, J = 3.8 Hz). This belonged to 
an equatorial proton; observation of coupling between this proton and the signals 
at δH 1.78 and 1.53 in the DQF-COSY spectrum indicated that the latter signals 
should be the C-6 methylene protons (Bruno et al., 2002). 1D TOCSY 
experiments led us to establish the spin system H-1H-3 showing the presence 
of a hydroxymethyne group at C-1 and C-3. HMBC correlations between H-3 
and C-3, C-5, and Me-19; H-1 and C-5 and Me-20; Me-20 and C-1, C-5, C-8, C-
9, and C-10; H-5 and C-3, C-7, C-9, C-18, and Me-19 were also observed. All 
other methylene and methyne proton signals extended between 1.4 and 2.6 ppm 
in the 1H NMR spectrum (Table 4.1). The 13C NMR assignements for 1 were 
confirmed by DQF-COSY, HSQC, and HMBC correlations. All the obtained 
data indicated the structure to be ent-1α,3α,7β,18-tetrahydroxykaur-16-ene for 
compound 1. 
Compound 2 was assigned the molecular formula C20H32O3, as established by 
HRESIMS ([M+Na]+ at m/z 343.2141) and 13C NMR. The 1H NMR spectrum 
(Table 4.1) displayed signals due to two tertiary methyl groups at δ 0.74 and 
1.29, one hydroxymethylene group at δ 3.27 and 3.53, and one exomethylene 
group at δ 4.71 and 4.85. The 13C NMR experiments revealed the presence of 
twenty carbon signals. A comparison of these carbon resonances with those of 
the related kaurene diterpenes suggested that 2 possessed the same skeleton (de 
Quesada et al., 1972). The 1H NMR spectrum of 2 combined with the 
observation from the 1D TOCSY and DQF-COSY experiments suggested the 
sequences C-1C-3, C-5C-7, C-9C-14, and C-15C-17. The location of 
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the functional groups were confirmed by the key correlations observed in the 
HMBC experiment; thus, the signal of H2-17 correlated with C-13 and C-15, that 
of H-14b with C-7, C-9, C-12, C-15, and C-16, and that of H-11 with C-9, C-10, 
and C-13, permitting the exomethylene function to be located at C-16/C-17 and 
an hydroxymethyne group to be placed at C-11. The signal of H-3 correlated with 
C-1, C-5, and Me-19, that of H2-18 with C-3, C-4, C-5, and Me-19 allowing a C-
3 and C-18 hydroxyl groups to be established. The analysis of the coupling 
constants of H-3 (dd, J = 11.6, 4.5 Hz) and H-11 (br dd, J = 12.0, 6.5 Hz) showed 
an axial orientation, indicating therefore the α-configuration of the C-3 and C-11 
hydroxyl groups. Consequently, compound 2 was established as ent-3α,11α,18-
trihydroxykaur-16-ene. 
Compound 3 (C19H30O4) showed an [M+Na]+ peak at m/z 345.2029. Its 1H NMR 
spectrum (Table 4.1) showed two methyl singlets at δ 0.78 and 1.19, a 
hydroxymethyelene group at δ 3.34 and 3.55 (both d, J = 12.0 Hz) adjacent to a 
quaternary carbon, and two hydroxymethynes a δ 3.67 and 3.70. From the 1D 
TOCSY, DQF-COSY and HSQC spectroscopic data, the spin systems C-1C-3, 
C-5C-7, C-9C-14 were established. The presence of a hydroxyl group at C-3 
was revealed as a dd (J = 12.0, 5.2 Hz) and the corresponding C-3 carbon signal 
was observed at 74.2 ppm. This chemical shift and the doublet of doublets are 
characteristic signals for the α position of C-3 (Gonzalez et al., 1981; Fraga et 
al., 1987). The presence of a triplet at δ 3.70 (J = 3.5 Hz) was indicative of a 
characteristic H-7α proton, as observed in similar kaurane diterpenes (Venturella, 
1975). The 13C NMR spectrum of compound 3 (Table 4.3) showed nineteen 
signals whose assignments were carried out by HSQC and HMBC experiments. 
The cross peak signals between H-15a and C-9, C-13, and C-14, and H-13 and C-
8, C-11, C-15, and C-16 indicated that a carbonyl group was situated at C-16. So, 
the structure of 3 was determined to be ent-3α,7β,18-trihydroxy-17-nor-kauran-
16-one. 
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The NMR spectroscopic data of 4 (C21H32O5; HRESIMS at m/z 387.2180 
[M+Na]+) suggested that its structure resembled that of 3 but differed in the 
presence of an acetyl group. The main differences in the 1H NMR spectrum 
resided in the chemical shifts of an AB system at C-18 (δ 3.87 and 4.03 in 4 
versus δ 3.34 and 3.55 in 3). Compound 4 had identical spectroscopic data that 
ent-3α,7β-dihydroxy-18-acetyloxy-17-norkauran-16-one previously obtained 
from ozonolysis of linearol (Bruno et al. 2001). 
Analysis of the DQF-COSY and HSQC experiments of 5 (C22H36O6; HRESIMS 
at m/z 419.5332 [M+Na]+) indicated the presence of the same partial structure in 
rings A, B, and C, as that of 4 but showed that ring D was different. In the NMR 
spectra of compound 5 the presence of 16,17-diol group (a hydroxymethylene at 
δ 3.63 and 3.73 and a quaternary hydroxylated carbon at δ 81.8) was observed. 
This was confirmed by the HMBC correlations of H2-17 and C-13, C-15, and C-
16 and H-15a and C-9, C-13, and C-17. Thus, the structure of 5 was determined 
to be ent-3α,7β,16α,17-tetrahydroxy-18-acetyloxy-kaurane. 
The HRESIMS of compound 6 (C20H34O4) showed a molecular ion peak at m/z 
361.2896 [M+Na]+. Analysis of NMR data of 6 and comparison with those of 5 
exhibited that 6 differed from 5 only by the absence of the OH group at C-3 and 
the acetyl group at C-18 (Tables 4.2 and 4.3). This compound was previously 
obtained by biotransformation of candicandiol (Fraga et al., 2003). Thus 
compound 6 was identified as ent-7β,16α,17,18-tetrahydroxykaurane. 
Compound 7 molecular formula was determined as C36H48O19 by high-resolution 
electrospray ionization mass spectrometry (HR-ESIMS) (m/z 807.2660 
[M+Na]+). Its ESIMS spectrum showed a quasimolecular ion peak at m/z 807 
[M+Na]+; two main fragments at m/z 675 [M+Na-132]+ and 529 [M+Na-132-
146]+ due to the loss of one pentose and one deoxyhexose moiety were also 
observed. The 13C NMR spectrum (Table 4.4) of 7 displayed 36 signals, of 
which 19 were assigned to the aglycone moiety; the remaining 17 signals 
corresponded to two hexoses and one pentose sugar residues. The 1H NMR 
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spectrum (Table 4.4) of 7 displayed proton signals characteristic of a t-feruloyl 
group (three aromatic protons resonating at δ 6.80 (1H, d, J = 8.0 Hz), 7.02 (1H, 
dd, J = 8.0, 2.0 Hz), 7.17 (1H, d, J = 2.0 Hz) as an ABX system and two trans 
olefinic protons as an AB system at δ 6.40 and 7.63 (J = 16.0 Hz), and 3-
methoxy-4-hydroxyphenylethanol moiety [three aromatic protons at δ 6.64 (1H, 
dd, J = 8.0, 2.0 Hz), 6.66 (1H, d, J = 2.0 Hz), 6.69 (1H, d, J = 8.0 Hz) as an ABX 
system and an A2B2 system assigned to a hydroxyethyl group at δ 2.81 (2H, m), 
3.78 (1H, m), 4.04 (1H, m)] (Karioti et al. 2003); two methoxyl groups at δ 3.75 
and 3.87 were also observed. Additionally, three signals assignable to anomeric 
protons indicated the presence of three sugar moieties whose identification was 
obtained from 1D TOCSY, DQF-COSY and HSQC experiment as β-glucose, α-
rhamnose, and α-arabinose. All the 1H and 13C NMR signals were assigned with 
the aid of 2D NMR spectra including 1D-TOCSY, DQF-COSY, HSQC, and 
HMBC spectra. The downfield shift of C-3 (84.0 ppm) of glucose indicated that 
this position was a glycosylation site. This finding was further confirmed by 
HMBC experiment, where a crosspeak between H-1rha (δ 5.49) and C-3glc (84.0 
ppm) was observed. The carbon resonances assigned to the α-arabinose unit 
suggested its terminal position. A further site of connectivity was proved to be C-
2 of rhamnose, on the basis of 1H and 13C NMR spectra, as well as HMBC 
correlations between H-1ara (δ 4.33) and C-2rha (82.5 ppm). The acylation site was 
on C-6 of glucose as evidenced by the strong deshielding of H-6aglc and H-6bglc at 
δ 4.37 and 4.50 and the crosspeak between H2-6glc and COO at 169.2 ppm. The 
configuration of the sugar units was assigned after hydrolysis of 7 with 1N HCl 
and GC analysis of trimethylsilylated sugar through a chiral column. Thus, 
compound 7 was determined to be the new phenylpropanoid glycoside β-(3-
methoxy-4-hydroxyphenyl)-ethyl-O-α-L-arabinopiranosyl-(1→2)-α-L-
rhamnopyranosyl-(1→3)-6-O-t-feruloyl-β-D-glucopyranoside.  
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The HRESIMS of 8 (C35H46O19) showed a sodiated molecular ion at m/z 
793.4194 [M+Na]+. Analysis of NMR data of compound 8 and comparison with 
those of 7 showed 8 to differ from 7 only in the absence of a methoxyl group of 
the aglycon (Table 4.4). Therefore, the structure β-(3,4-dihydroxyphenyl)-ethyl-
O-α-L-arabinopiranosyl-(1→2)-α-L-rhamnopyranosyl-(1→3)-6-O-t-feruloyl-β-
D-glucopyranoside was assigned to 8. 
  
Phytochemical studies Chapter 4 
 
73 
 
CH2OH
10
OCOCH3
13
HO
HO OH
OH
OCOCH3
9
O
CH2OH
HO OH
 
 
Figure 4.4: Structures of known diterpenes isolated from S. pullulans 
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Figure 4.5: Structures of known compounds isolated from S. pullulans  
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Table 4.1: 1H and data of 1-3 (Methanol-d4, 600 MHz)a 
position 1 2 3 
 
   
1a 3.38 dd (12.0, 5.0) 1.14 br dd (13.0, 10.7) 1.02 ddd (14.0, 13.0, 4.0) 
1b  2.77 ddd (13.4, 6.0, 2.8) 1.89b  
2a 1.67 m 1.65 m 1.74b 
2b 1.80b 1.72 m 1.81b 
3a 3.70 dd (12.0, 5.7) 3.66 dd (11.6, 4.5) 3.67 dd (12.0, 5.2) 
3b    
5 1.80b 1.25 br d (10.5) 1.87 br d (11.0) 
6a 1.63b 1.48b 1.61b 
6b 1.78b 1.50b 1.67 m 
7a 3.53 t (3.8) 1.52b 3.70 t (3.5) 
7b  1.58b  
9 1.70 dd (11.0, 5.0) 1.56b 1.60b 
11a 1.63b 4.25 br dd (12.0, 6.5) 1.52 m 
11b 1.65b  1.89b 
12a 1.43 dd (7.0, 2.0) 1.77 m 1.40 m 
12b 1.77b 1.90 ddd (13.0, 9.0, 1.5) 1.76b 
13 2.64 m 2.70 m 2.39 m 
14a 1.18 m 1.07 dd (12.4, 4.5) 1.54 dd (11.8, 4.5) 
14b 1.90 dd (9.0, 2.0) 2.23 br d (11.6) 2.23 br d (11.8) 
15a 2.26 br s 2.01 dd (12.8, 2.0) 2.11 d (12.2) 
15b  2.12 d (12.8) 2.20 d (12.2) 
17a 4.76 br s 4.79 br s  
17b  4.85 br s  
18a 3.32 d (11.7) 3.27 d (11.4) 3.34 d (12.0) 
18b 3.54 d (11.7) 3.53 (11.4) 3.55 (12.0) 
19 0.72 s 0.74 s 0.78 s 
20 1.15 s 1.29 s 1.19 s 
CH3    
 
 
a
 J values are in parentheses and reported in Hz; chemical shifts are given in ppm; 
assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC 
experiments. 
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Table 4.2: 1H NMR data of 4-6 (Methanol-d4, 600 MHz)a 
a
 J values are in parentheses and reported in Hz; chemical shifts are given in ppm; 
assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC 
experiments. 
b
 overlapped signals 
 
 
 
 
 
 
 
 
 
  
position 4                           5                                                                  6 
 
  
1a 1.06 br dd (13.0, 11.0) 1.02 br dd (13.0, 11.0) 0.84 br dd (12.0, 6.0) 
1b 1.91b 1.92 ddd (13.5, 6.0, 2.5) 1.76b 
2a 1.70 m 1.34 m 1.14 m 
2b 1.82b 1.42 m 1.35b 
3a 3.65 dd (12.2, 5.0) 3.61 dd (12.0, 4.5) 1.33b 
3b   1.86b 
5 2.00 br d (12.0) 1.87 br d (13.5) 1.74b 
6a 1.57b 1.58b 1.60b 
6b 1.77b 1.60b 1.62b 
7a 3.67 t (2.5) 3.62 t (3.5) 3.62 t (3.0) 
7b    
9 1.61 dd (11.4, 5.5) 1.46 dd (11.4, 6.0) 1.46 dd (9.0, 4.5) 
11a 1.54b 1.62b 1.70b 
11b 1.84b  1.80b 
12a 1.78b 1.54 m 1.60b 
12b 1.89b 1.63b 1.70b 
13 2.40 m 2.08 m 2.07 m 
14a 1.55b 1.70 m 1.68b 
14b 2.22 br d (11.6) 1.83 dd (9.5, 2.0) 1.89dd (11.0, 3.0) 
15a 2.14 br s 1.59b 1.56 d (14.0) 
15b  1.78 d (12.2) 1.75b 
17a  3.63 d (11.0) 3.64 d (11.5) 
17b  3.73 d (11.0) 3.72 d (11.5) 
18a 3.87 d (11.4) 3.86 d (11.3) 3.11 d (11.5) 
18b 4.03 d (11.4) 3.99 d (11.3) 3.32 d (11.5) 
19 0.78 s 0.76 s 0.81 s 
20 1.19 s 1.13 s 1.14 s 
CH3 2.07 s 2.07 s  
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Table 4.3: 13C NMR data of 1-6 (Methanol-d4, 600 MHz)a 
 
 1 2 3 4 5 6 
carbon       
1 80.0 41.0 39.1 39.4 38.8 40.0 
2 37.5 27.0 27.1 27.2 29.9 19.0 
3 71.4 73.2 74.2 72.2 72.4 36.5 
4 42.6 43.9 42.6 42.4 42.0 37.5 
5 37.5 49.0 39.7 39.2 39.2 40.8 
6 27.0 20.7 27.1 27.0 27.0 27.0 
7 77.6 42.5 77.0 77.1 77.5 77.8 
8 46.0 47.0 50.0 50.9 50.9 50.7 
9 51.6 61.5 50.3 51.6 51.0 51.5 
10 38.0 41.2 39.0 39.6 41.0 43.0 
11 20.0 70.7 18.8 19.3 19.1 19.0 
12 34.6 42.5 30.5 30.6 27.0 27.0 
13 45.1 44.4 48.9 48.8 46.0 45.8 
14 39.9 40.3 36.5 36.8 37.0 35.0 
15 45.5 49.5 52.2 52.6 50.1 50.0 
16 156.0 156.0 225.0 225.0 81.8 82.4 
17 102.8 103.2   66.5 66.4 
18 67.6 67.2 68.0 66.5 66.5 71.8 
19 12.5 12.8 12.3 12.4 12.6 17.0 
20 13.6 19.4 18.3 18.6 18.3 18.2 
C=O    173.5 173.0  
CH3    20.9 20.5  
a
 Chemical shifts are given in ppm; assignments were confirmed by HSQC and 
HMBC experiments. 
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Table 4.4: 1H and 13C NMR data of 7-8 (Methanol-d4, 600 MHz)a 
 7  8  
position δH δC δH δC 
Aglycone     
1  131.6  130.2 
2 6.66 d (2.0) 115.3 6.61 d (2.0) 116.0 
3  148.8  146.2 
4  145.9  145.0 
5 6.69 d (8.0) 116.7 6.68 d (8.0) 117.0 
6 6.64 dd (8.0, 2.0) 121.0 6.54 dd (8.0, 2.0) 120.6 
α 3.78 m 72.1 3.77 m 72.0 
 
4.04 m  3.95 m  
β 2.81 m 36.6 2.79 m 36.7 
OMe 3.75 s 56.3   
β-glucose     
1 4.34 d (7.8) 104.2 4.33 d (7.8) 104.0 
2 3.54 dd (9.0, 7.8) 75.3 3.54 dd (9.0, 7.8) 75.2 
3 3.49 t (9.0) 84.0 3.49 t (9.0) 84.0 
4 3.41 t (9.0) 70.3 3.42 t (9.0) 70.3 
5 3.34 m 75.6 3.29 m 75.4 
6a 4.37 dd (12.0, 5.0) 64.4 4.35 dd (12.0, 5.0) 64.2 
6b 4.50 dd (12.0, 2.5)  4.50 dd (12.0, 2.5)  
α-rhamnose     
1 5.49 d (1.8) 101.5 5.48 d (1.8) 101.4 
2 3.98 dd (3.0, 1.8) 82.5 3.98 dd (3.0, 1.8) 82.4 
3 3.63 dd (9.0, 3.5) 72.5 3.66 dd (9.0, 3.5) 72.5 
4 3.48 t (9.0) 74.1 3.45 t (9.0) 74.1 
5 4.00 m 69.6 3.98 m 69.7 
6 1.24 d (6.5) 17.7 1.23 d (6.5) 17.5 
α-arabinose     
1 4.33 d (7.5) 107.3 4.35 d (7.5) 107.2 
2 3.65 dd (9.0, 7.5) 72.0 3.60 dd (9.0, 7.5) 72.6 
3 3.50 dd (9.0, 3.0) 74.2 3.50 dd (9.0, 3.0) 74.0 
4 3.79 m 69.6 3.77 m 69.7 
5a 3.54 dd (12.0, 3.0) 67.2 3.54 dd (12.0, 3.0) 67.3 
5b 3.87 (12.0, 2.0)  3.86 (12.0, 2.0)  
Acyl moiety     
1  127.7  128.0 
2 7.17 d (2.0) 111.4 7.17 d (2.0) 111.1 
3  149.4  149.5 
4  150.8  150.7 
5 6.80 d (8.0) 116.1 6.81 d (8.0) 116.4 
6 7.02 dd (8.0, 2.0) 124.0 7.02 dd (8.0, 2.0) 124.1 
α 6.40 d (16.0)  115.0 6.39 d (16.0)  115.0 
β 7.63 d (16.0) 147.0 7.63 d (16.0) 147.1 
CO  169.2  169.4 
OMe 3.87 s 56.3 3.87 s 56.3 
a
 J values are in parentheses and reported in Hz; chemical shifts are 
given in ppm; assignments were confirmed by DQF-COSY, 1D-
TOCSY, HSQC, and HMBC experiments. 
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Chapter 5 
 
5.1 Introduction 
 
5.1.1 ent-Kaurane diterpenes: 15-ketoatractyligenin methyl ester 
 
Atractyligenin (Figure 5.1), is the nor-diterpene aglycon of the glucoside 
atractyloside, which occurs, together with its homologous diterpene, 
carboxyatractyloside, in the roots of Atractylis gummifera L. (Asteraceae). 
Atractyloside is the main compound responsible for the lethality of A. gummifera 
and Wedelia glauca Ort. (Asteraceae) in bovine cattle from some regions of 
Argentina, Brazil, and Uruguay, causing hypoglycemia, respiratory depression, 
nephrotoxicity, hypoxemia, and cell injury. In humans, the poisoning with this 
glycoside can cause renal and hepatic failure, also followed by necrosis.  
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Figure 5.1: Structure of atractyligenin 
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This toxic action is due, mainly, to the inhibition of mitochondrial oxidative 
phosphorylation (Garcia et al., 2007). Our interest in this compound was 
stimulated both by the high toxicity of the glucoside and by the antimicrobial and 
cytotoxic activities of some derivatives: atractylgenin and its derivatives showed 
significant cytotoxic activity against different cancer cell lines. The main 
structural feature for cytotoxic activity of these compounds and other natural 
compounds was established to be the presence of an α,β-unsaturated system, 
which likely serves as an alkylating center and can be part of an ester, ketone, or 
lactone moiety. On the basis of this information, extensive chemical work has 
been carried out by the research group of the Dipartimento di Chimica Organica 
di Palermo on the structure of atractyligenin. The 15-hydroxy group of 
atractyligenin was converted into a ketone in order to incorporate an α,β-
unsaturated ketone into the ent-kaurane skeleton. 
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Figure 5.2: Reaction scheme of 15-ketoatractyligenin methyl ester synthesis 
 
 
Atractyligenin methyl ester (2), prepared by treating atractyligenin (1) with 
CH2N2, was reacted with MnO2 for 3 min, obtaining 15-ketoatractyligenin 
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methylester (compound 3, SR2017) as main compound and 2,15-
diketoatractyligenin methyl ester as minor product (4, Figure 5.2).  
Other analogoues were sinthetized and screened against a panel of human tumor 
cell lines including A549 (lung), PC-3 (prostate), 1A9 (ovarian), MCF-7 (breast), 
KB (nasopharyngeal), and KB-VIN (multidrug-resistant KB subline) in order to 
explore their cytotoxic activity and critical drug-resistance profile. Diterpenes 
lacking of an α,β-unsaturated ketone group were inactive.  
Compound 3, together with the analogue 2,15-ketoatractyligenin methyl ester 
showed cytotoxic activity against all six tested cancer cell lines and were most 
potent against 1A9 ovarian cancer cells with half maximal inhibitory 
concentration (IC50) values of 0.2 and 0.3 µM, respectively (Rosselli et al., 
2007). Before starting with further studies, the antitumor potential of SR2017 
was also evaluated from Prof. M.A. Belisario of Dipartimento di Farmacia, 
Università di of Salerno, using HCT-116 (colon carcinoma) Jurkat (T-cell 
leukemia), HepG2 (hepatoblastoma), MCF7 (breast carcinoma) tumor cell lines. 
SR2017 displayed strong cell growth inhibitory potency in all tested cell lines, 
IC50 values ranging between 1.5 and 10 µM. Leukemia-derived cells, and in 
particular Jurkat cells, displayed higher susceptibility to SR2017 than solid 
tumor-derived cell lines. Among the solid tumor-derived cell, HCT-116 were the 
most susceptible and so they were adopted to evaluate the antitumoral activity of 
SR2017 in vivo. After 7 day from the subcutaneous injection of HCTT-116 colon 
carcinoma cells, treatments with daily delivery of SR2017 at 10 mg/kg in 100 ul 
of vehicle for 7 days were performed. There was an inhibition of the tumor 
growth costant during the treatment. No evident sign of toxicity was revealed.  
In the light of this information, we decided to investigate the mechanism of 
action of these actratylignin derivatives researching first of all their molecular 
targets. 
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5.1.2 Starting point for a fishing for partners approach 
 
SR2017 and 2,15-ketoatractyligenin methyl ester could be interesting new lead 
compounds for further investigation, so the objective was to identify the primary 
SR2017 partners, suitable as potential therapeutic targets. 
In chapter 1 a fishing for partner (or pull down) technique was described as a 
chemical proteomic approach aimed to the identification of molecular target for 
small molecules. This kind of study was used in the research of SR2017 targets, 
as reported in this chapter, and was carried out in collaboration with Prof. N. De 
Tomamasi team of Dipartimento di Farmacia, Università di Salerno, where I 
spent a training period. 
To reach this goal, a chemical proteomic strategy, using affinity 
chromatography coupled with mass spectrometry, has been applied. It was started 
a screening aimed to the identification of intracellular target(s) of SR2017 chosen 
as representative of a library of ent-kaurane diterpenes instead of 2,15-
ketoatractyligenin methylester for the presence of its hydroxylic group at position 
2, suitable for the successive steps of chemical immobilization on a solid support.  
From an experimental point of view, this work can be divided into the 
following steps: (i) chemical immobilization of SR017 on a solid support; (ii) 
incubation of SR2017 modified beads with cell lysates; (iii) MS identification of  
SR2017 interactors; (iv) determination of physical interaction between SR2017 
and the identified partners. 
 
5.2 Chemical immobilization of SR2017 on a solid support 
 
The compound-immobilized affinity chromatography is a powerful versatile 
method to profile cellular targets of selected drug candidates. The procedure 
involves immobilization of the compound on a solid support through a spacer 
arm and the use of this matrix as a bait to fish for interacting proteins in a cellular 
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lysate or tissue extract (Raida, 2011, Rix et al., 2009). The chemical 
immobilization of a small molecule ligand is usually achieved through suitable 
functional group. SR2017 was anchored onto a solid support, taking advantage of 
its hydroxylic group at position C-2. An epoxy-activated Sepharose 6B resin, 
formed by reacting Sepharose 6B with 1,4-bis (2,3-epoxy-propoxy)-butane was 
used (Figure 5.3). A basic solution of 15-ketoatractylgenin was added to the 
swelled epoxy resin, the reaction was monitored by HPLC, and the yield was 
calculated by the integration of peaks relative to the SR2017 concentration in the 
surnatant before and after 24 h from the coupling. 
 
 
O
HO
COOCH3
O
COOCH3
OHO O
i
(i) ACN 50%, NaHCO3, 50 mM pH 12, 50%    
    24 h  under stirring
 
Figure 5.3: Reaction’s scheme of SR2017 with epoxy groups of swelled epoxy-
activated Sepharose 6B resin  
 
 
Each peak was also checked by ESI-MS in positive mode (Figure 5.4). The 
coupling process was completed by blocking the exceeding active epoxy groups 
with an ethanolamine solution. As a control, a portion of the resin was capped 
only with ethanolamine.  
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Before the terminal 1,4
there is a spacer of 12 carbon atoms that plays an important role to avoid possible 
steric hindrance between the macromolecular target(s) and the immobilized 
ligand. For the choice of the solid support it is very cr
and the hydrophilic properties of the spacer in order to minimize non
protein binding and maximize purification efficiency. The experimental 
conditions (buffer, pH, reaction time and temperature) were optimized in orde
reach a final concentration of 
advices. 
 
5.3 Identification of 
method 
 
The crude cell extract
beads to promote the interaction between SR2017 and its potential partners in the 
cell lysate. An equal amount of cell lysate was loaded onto the covalently 
coupled beads and onto unmodified beads in parallel to
proteins specific interaction with SR2017 and the unspecific background.
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extensive washings, the SR2017 
by elution with SDS-gel loading buffer. The protein mixtures were then resolved 
by SDS-PAGE and some differences were evident al
visualization (Figure 5.5).
 Since the simple gel visualization wasn’t
differences, the gel lanes, of the SR2017 beads and control experiments were
both cut in 13 pieces, digested with trypsin, and analyzed by mass spectrometry 
through nanoflow RP-HPLC MS/MS.
obtained in the conventional MS
spectra converted into a peak list. All peak lists
database search for the protein identification.
triplicate. 
 
 
Figure 5.5: SDS PAGE analysis of the affinity purified
control, (
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 enough to establish significative 
 Double and triple charged peptide species 
 spectrum were fragmented, and all the MS/MS 
 were then submitted to a Mascot 
 The experiment was done in 
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A gel free analysis based only on affinity purification and mass spectrometry 
analysis of SR2017 partners was also necessary to minimize the interference of 
background contaminants and to increase the signals intensity of the proteic 
mixture and to have better results. All the steps until the incubation with the cell 
lysate were the same described before, but at the end the SR2017 interacting 
proteins were released from the resin by elution with guanidine instead of SDS-
gel loading buffer. The proteins were digested by trypsin directly in solution. The 
tryptic digests were analyzed by mass spectrometry and the resulting peak lists 
were elaborated as previously described. The experiment was done in triplicate. 
 
5.4 Database search to characterize the targets 
 
The Mascot database search revealed the whole interactome of SR2017. A list 
of identified proteins, from both gel lanes (control and matrix with SR2017) and 
from both analytic methods (with the gel and gel-free), was obtained and 
compared to establish which proteins specifically interact with SR2017.  
By this way three proteins were found: Heat shock protein 70 kDa (Hsp70) 
(Figure 5.6), Heat shock protein 60 kDa (Hsp60) and Peroxisomeproliferator-
activated receptor gamma (PPARγ); (Figure 5.7).  
The Heat shock proteins (Hsp) are mainly ATP-dependent molecular 
chaperones. Hsp70, together with other chaperones, is essential for the folding, 
translocation and assembly of the proteins both in physiological situation and in 
stress condition (Figure 5.7). In stress condition they stabilize the damaged 
proteins in order to promote their renaturation or degradation (Mosser et al. 
2004). Some of them are constitutively abundant while some other, like Hsp70, 
are over-expressed especially in many tumor cells. They seems to have a role in 
the regulation of cellular proliferation and apoptosis (Schmitt et al., 2007). 
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Figure 5.6: Hsp70ATPasic site (Flaherty et al., 1990) 
 
 
 It is known that Hsp70 has a cytoprotective action due to anti-apoptotic 
effects through upstream and downstream mitochondrial signaling pathways 
(Didelot et al., 2007). Hsp70 inhibits the caspase dependent and independent 
apoptosis in Jurkat cells (Creagh et al., 2000). Hsp70 seems to block the caspase 
activation and by this way it inhibits the mitochondrial damage and the nuclear 
fragmentation. Furthermore the direct binding between Hsp70 and apoptosis 
proteases-activating factor (Apaf-1) prevents the recruitment of pro-caspase 9 of 
the apoptosome. Nevertheless, other studies assert that the apoptosis caspase 
dependent inhibition mediated by Hsp70 is related to the release of the 
mitochondrial cytochrome c through the translocation of Bax (Bcl-2–associated 
X protein), a pro-apoptotic protein, from cytosol to mitochondria (Mosser and 
Morimoto, 2004). The apoptosis caspase independent inhibition is due to the 
binding between Hsp70 and apoptosis-inducing factor (AIF) with the consequent 
inhibition of the chromatin condensation induced by AIF (Schmitt et al., 2007). 
The pathway in which Hsp70 is involved it is very complex and this protein is an 
interesting target for the anti-cancer therapy. 
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Hsp60 is a mitochondrial chaperone that is involved in the folding of native 
proteins and in the intracellular proteins trafficking (Cappello et al., 2008). This 
protein is also present in the cytosol and in tumor cells its level is high and is 
considered as a marker of immune system damage since it causes the activation 
and the maturation of dendritic cells and cytotoxic T cells (Osterloh et al., 2008). 
Hsp60 can be found even in extracellular space where it can interact with various 
receptor with pro or anti-inflammatory effects (Steinhoff et al., 1999). It is 
involved in the apoptotic process and it can explicate both pro-apoptotic than 
anti-apoptotic effects. It makes a complex with p53 and also stabilizes the 
surviving pools that usually with their degradation promote the apoptotic process 
(Ghosh et al., 2008). An over-expression of Hsp60 together with Hsp10 leads to 
a decrease of anti-apoptotic factor, such as Bcl-xl and Bcl-2, and is related to the 
presence of Bax, a pro-apoptotic protein (Shan et al., 2003). The pro-apoptotic 
effect of Hsp60 is also related to caspases activation (Samali et al., 1999).  
Peroxisomeproliferator-activated receptors PPARs, members of the nuclear 
hormone receptor (NHR) family, are ligand-activated transcription factors. They 
were first identified as the nuclear receptors that mediate the pleiotropic effects 
of peroxisome proliferators. As indicated by the name, peroxisome proliferators 
are a collection of structurally diverse chemicals (i.e. steroids, lipids, 
hypolipidemic drugs, plasticizers, etc.) that cause hepatomegaly in rodents. The 
three known PPAR isotypes PPARα, PPARβ/δ and PPARγ are involved in 
numerous biological processes that range from lipid, glucose, and energy 
homeostasis to inflammation and wound repair. Following activation by ligands, 
PPARs heterodimerize with retinoid X receptor (RXR or NR2B), bind to the 
peroxisomeproliferator response element (PPRE) present in the promoter regions 
of target genes, recruit co-activators, and activate transcription of target genes 
(Mora et al., 2006). Each isoform is encoded by a different gene activated by a 
selective ligand. PPARα is especially expressed in liver, hearth, kidney proximal 
tubule cells and intestine; PPARβ/δ is expressed in many tissue and PPARγ is 
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mainly found in adipocytes and it plays an important role in the adipocytes 
differentiation but it is also present in endothelial cells and in immune system 
cell (Kliewer et al., 1994). They can interact with many kind of ligand and 
consequently they present different function. PPARs are naturally activated by 
lipids through diet or other biosynthetic ways and by fatty acids like 
prostaglandins and leukotrienes (Krey et al., 1997). 
PPARγ has a molecular weight of 57.6 kDa and is involved in the lipids 
biosynthesis and in the carbohydrates metabolism. The activation of this receptor 
in diabetic patients causes a decrease of the glucose concentration. The best 
known therapeutic application of PPARγ ligands is the use of thiazolidinediones 
(TZDs) as insulin sensitizers to treat type 2 diabetes. PPARγ agonists have an 
anti-inflammatory activity with the inhibition of the production of TNFα, IL-1b 
and IL-6. Agonists of PPARγ have been shown to inhibit growth and cell 
proliferation, promote terminal differentiation, and induce apoptosis in human 
breast tumor cells. A number of studies demonstrated that PPARγ agonists of 
different structural classes can inhibit growth, cause terminal differentiation, and 
induce apoptosis of human tumor cells derived from various tissues in vitro and 
in vivo. Other studies suggested that PPARγ activation may exert the opposite 
effect: the growth promotion (Han et al., 2004; Lee et al, 2006; Mora et al., 
2006). 
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Figure 5.7: (A,B) Hsp70 involvment in cell death; (
Peroxisome proliferator-activated receptors
5.5 Targets validation and characterization of physical interactions
 
Surface plasmon resonance (SPR) Biacore technology was employed to 
the interactions of SR2017 
technique, based on the evanescent wave phenomenon, able to measure changes 
in refractive index onto a sensor surface, and it is suitable for characteriz
macromolecular interactions (Casper 
compound in solution and its ligand immobilized on the sensor surface results in 
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a change of the refractive index, that could be monitored in real time allowing the 
measurement of association and dissociation rates. It is a real time biomolecular 
interaction analysis through which we attempted to measure the kinetic 
dissociation constants between SR2017 and the targets that were anchored 
separately onto the chip surface. This target validation method was necessary 
since the fishing for partners approach could give false positive results. Figure 
5.8 reported the sensograms detected after the binding of SR2017 and Hsp70 
(Figure 5.8 A) and SR2017 and PPARγ (Figure 5.8 B) at different protein 
concentrations of SR2017: 50 nM, 100 nM, 250 nM, 500 nM, 1 mM and 100 nM, 
250 nM, 500 nM respectively. The increase of response units (RU) in the 
association phase and the slope of the dissociation phase of the complex are 
clearly dependent on the analyte concentration. Association and dissociation rate 
constants were determined, and equilibrium binding constants (KD) of 42.3 ± 8.6 
nM and 89.3 ± 11.5 nM were calculated for Hsp70 and PPARγ complex, 
respectively. The analysis of the sensogram obtained by the immobilization of 
Hsp60 was instead negative. 
 
 
 
 
 
 
 
Figure 5.8: Sensorgrams obtained from immobilized Hsp 70 (A) and PPARγ (B)  
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5.6 Conclusion 
 
The results obtained for Hsp60 suggested that we could exclude this 
chaperone from the list of the SR2017 potential molecular targets. On the 
contrary, the data related to Hsp70 and PPARγ demonstrated instead the 
interaction occurring between the small molecule and these proteins. Given the 
activities of both proteins, these information are consistent with the effects on 
cells showed by SR2017, especially in relation with Hsp70. 
Regarding the interaction with PPARγ, it is known that its natural ligands, 
such as 15-deoxy-∆-12,14-prostaglandin J2 (15d-PGJ2) can give a Michael 
reaction with the cysteine 285 in the ligand-binding domain of the receptor for 
the presence of α,β-unsaturated keto group (Shiraki et al., 2005).  
However, further analysis are necessary to continue the target validation 
process and also biological assays are needed to clarify this molecule mechanism 
of action. 
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Chapter 6 
 
6.1 A chemical proteomics approach to discover Hsp27 as a target for 
proapoptotic clerodane diterpenes: summary of previous studies 
 
Compounds isolated from members of the Lamiaceae family are traditionally 
used as remediesagainst many diseases. Within the Lamiaceae, the genus Salvia 
is worthwhile to be studied, as it is endowed with bioactive diterpenes, 
commonly found in the complex secretion product of these plants, whose 
secretory structures are widely distributed on their aerial parts. Several 
clerodane-type diterpenes are commonly found in the complex secretion product 
of plants belonging to Salvia genus, whose secretory structures are widely 
distributed on their aerial parts (Duke and Oliva, 2004) and many of them have 
demonstrated antimicrobial, anti-inflammatory, anti-ulcer and cytotoxic activity 
(Rodiguez-Hann et al., 1992; Whitson et al., 2010; Vieira et al., 2011; 
Kanokmedhalkul et al., 2007). Despite all these well described actions, the 
molecular mechanisms by which this class of compounds exerts its effects are 
still unclear. In this context, during my undergraduated thesis, we started a 
fishing for partners study aimed to the identification of intracellular target(s) of 
hardwickiic acid (HAA, compound 1; Figure 6.1) chosen as representative of a 
library of clerodane diterpenes isolated from Salvia ssp. One of the most versatile 
methods to profile cellular targets of selected drug candidates is compound-
immobilized affinity chromatography.  
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Figure 6.1: Structure of compounds 1–16 
 
The procedure involves immobilization of the compound on a solid support 
through a spacer arm and the use of this matrix as a bait to fish for interacting 
proteins in a cellular lysate or tissue extract (Raida, 2011; Rix and Superti-Furga, 
2009). The power of affinity chromatography combined with advances in protein 
identification by sensitive and high-throughput mass spectrometric analysis 
offers huge potential to find out previously unrecognized activities and potential 
therapeutic applications.  
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The diterpene HAA was selected as a testing compound from a small 
clerodanes library (Figure 6.1) because of its 4-carboxyl group, allowing us to 
covalently bind the compound to a solid support, an agarose matrix activated 
with 1,10-carbonyldiimidazole and modified by 1,12-dodecanediamine as a 
spacer.  
Using this approach, described in chapter 5, we identified Heat Shock Protein 
27 (Hsp27), an antiapoptotic protein characterized for its tumorigenic and 
metastatic properties and now referenced as a major therapeutic target in many 
types of cancer (Ciocca and Calderwood, 2005) as an HAA target. Hsp27 has 
many diverse functions including chaperone activity, mRNA stabilization, 
inhibition of apoptosis, cell proliferation, and modulation of actin 
polymerization. Hsp27 can interfere with a number of cell death pathways 
induced by heat shock, oxidative stress or death receptor agonist (Paul et al., 
2010). Expression of Hsp27 is up-regulated in numerous types of tumors and 
promotes unfavorable outcome (Ciocca and Calderwood, 2005). Overexpression 
of this protein is frequently associated with increased resistance to radiotherapy 
and to anti-cancer drugs, such as cisplatin, doxorubicin, and etoposide (Zhang 
and Shin, 2007). Targeting Hsp27 by an antisense strategy increases cancer cell 
death in vitro and in vivo (Aloy et al., 2008). The involvement of this chaperone 
in many cellular processes related to apoptosis and cell proliferation (Mymrikov 
et al., 2011; Parcellier et al., 2003; Voss et al., 2007) led us to further investigate 
the interaction of clerodane diterpenes with this target.  
To confirm the binding between Hsp27 and HAA and to measure the 
parameters of the interaction, a Surface Plasmon Resonance (SPR) based binding 
assay was used obtaining a good sensogram with KD 269±35 nM, indicative of a 
good interaction. The same analysis was also performed using 15 terpenoids 
showing structural analogies with HAA (compounds 2–16 in Figure 6.1) in order 
to perform some structure–activity relationship evaluations.  
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Our results suggested that the interaction with Hsp27 was not affected by the 
dimension of the ligand while the furane ring played a critical role. During my 
PhD thesis, studies to evaluate the nature of the interaction between HAA and 
Hsp27 were performed in collaboration with the Prof. N. De Tommasi team of 
University of Salerno. 
 
6.2 Limited proteolysis 
 
In addition to SPR measurements, the validation of HAA–Hsp27 interaction 
was carried out by means of a panel of chemical and biological approaches, such 
as limited proteolysis and biochemical assays reported in this thesis work. On the 
basis of the previous preliminary results, a limited proteolysis-mass spectrometry 
based strategy was used to evaluate the effect of the interaction between HAA 
and Hsp27 on the protein structure and activity. This approach is based on the 
evidence that exposed, weakly structured, and flexible regions of a protein can be 
recognized by a proteolytic enzyme. The differences in the proteolytic patterns 
observed in the presence or in the absence of putative protein ligands can be 
analyzed to identify the protein regions involved in the molecular interactions 
(Casbarra et al., 2004). Compound 16 was used as a negative control since it 
didn’t show any interaction with Hsp27 in SPR analysis. As a first step of this 
study, we performed Hsp27 enzymatic digestion under strictly controlled 
conditions (buffer, temperature, incubation time and enzyme/substrate ratio), 
optimized to preserve the dimeric form of Hsp27 (protein concentration 1 mM) 
and the correct protein folding. Trypsin, chymotrypsin, and endoproteinase GluC 
were used as proteolytic agents. Digestion products were analyzed by mass 
spectrometry and the observed fragments were identified on the basis of their 
molecular weight, the selectivity of the used enzymes and their 
complementarities. Only the fragments released by a single hydrolytic event have 
been taken into account, in order to evaluate the proteolytic accessibility of the 
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intact protein. Under the experimental conditions used, the protein remained 
largely undigested. Only a limited number of fragments were released from the 
protein molecule, showing that its native conformation is susceptible to 
proteolysis at a few very specific, and probably flexible, sites (Figure 6.2A): 
most of them are located in the N-terminal domain of the protein, in agreement 
with previous observations depicting this region as poorly structured (Baranova 
et al., 2009; 2011). Interestingly, a good agreement between the results achieved 
with the three enzymes was observed. When the same experiments were 
performed by pre-incubating Hsp27 with HAA, a different proteolytic pattern 
was observed (Figure 6.2B). Even if compounds 3 and 4 showed an affinity 
towards immobilized Hsp27 slightly higher than that measured for HAA, their 
low solubility and the small amount available led us to keep on using HAA as the 
testing compound. First of all, a higher amount of undigested protein was 
observed, regardless of the proteolytic enzyme used; besides, some of the sites 
prone to enzymatic hydrolysis in the N-terminal domain of the protein were 
protected following the Hsp27 interaction with HAA. In particular all the 
cleavage sites detected in the portion 26–36 escaped from hydrolysis in the 
complex, thus suggesting this region to be involved in the Hsp27 interaction with 
the diterpene. Experiments carried out on pre-incubating Hsp27 with compound 
16 produced a proteolytic pattern superimposable to that observed for the protein. 
All the limited proteolysis detailed data are provided in ESI-MS. 
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Figure 6.2: Preferential cleavage sites observed submitting to limited proteolysis 
Hsp27 (A) or Hsp27/1 complex (B). Schematic representation of structural organization 
of Hsp27. (C): α-crystalline domain is underlined in grey and WFPD motif is in black. 
Reported and putative phosphorylation sites are indicated by large or small black circles, 
respectively 
 
 
Hsp27 is composed of 205 aminoacids, its structure consists of N-terminal 
domain that includes the so-called WDPFmotif, the α-crystalline domain, and a 
short C-terminal sequence (Figure 6.2C) (Mymrikov et al., 2011). Both the 
WDPF-motif and the α-crystalline domain seem to be important for Hsp27 
oligomerization; this small heat shock protein can form variable size oligomers 
of up to 800 k8Da (Leji-Garolla and Mouk, 2005) and the state of 
oligomerization depends on many different factors such as post-translational 
modifications (phosphorylation and thiolation) and physical parameters (pH and 
temperature) (Leji-Garolla and Mouk, 2006; Rogalla et al., 1999). In particular, 
phosphorylation leads to formation of small oligomers, while increase in the 
temperature or decrease in the pH leads to large oligomers. Ser26 is a putative 
phosphorylation site that stands just at the beginning of the interaction region 
between the protein and the HAA, suggesting that the small molecule could 
influence the posttranslational modification of this residue. But, more probably, 
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the binding with the diterpene clerodane could provoke a conformational change 
of Hsp27 influencing the interaction with its protein targets. 
 
6.3 Insuline and citrate synthase aggregation assays 
 
The ability of HAA to modulate the in vitro chaperone activity of Hsp27 was 
evaluated by monitoring the insulin dithiothreitol (DTT) induced (Leji-Garolla 
and Mouk, 2006) and the citrate synthase (CS) thermal induced (Rogalla et al., 
1999) aggregation in the presence of Hsp27, with or without HAA or compound 
16, used as a negative control. The molecular chaperone activity of small heat 
shock proteins is often evaluated by DTT reduction of insulin. Reduction breaks 
the disulfide bonds holding together insulin chains A and B whereupon chain B 
aggregates but this aggregation can be prevented by adding stoichiometric 
amounts of Hsp27 (Figure 6.3A). When a 4-fold molar excess of HAA was 
added to this mixture, the slope of the curve became comparable to that observed 
without the chaperone, suggesting the inhibition of Hsp27 chaperone activity by 
this compound. Conversely, the presence of compound 16 did not perturb the 
Hsp27 antiaggregation effect. Similar results were achieved by evaluating the 
effects of Hsp27 on CS thermal induced aggregation. Upon incubation at 
elevated temperatures, CS underwent quantitative protein aggregation but the 
presence of  stoichiometric amounts of Hsp27 changed the aggregation kinetics 
significantly (Figure 6.3B). Again, adding a 4-fold molar excess of HAA the 
anti-aggregation effect of Hsp27 was substantially reverted, whereas the same 
amount of compound 16 did not produce any sensible effect. These results 
demonstrate that when HAA binds to the small heat shock protein it influences 
the ability of Hsp27 to interact with denatured proteins in vitro. 
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6.4 Apoptosis evaluation by analysis of hypodiploid nuclei 
 
In the effort to give a cellular significance to Hsp27–HAA interaction, it was 
decided to explore the pro-apoptotic activity of the small molecule in human 
monocytes. Hsp27 has recently been shown to be highly and constitutively 
expressed in human monocytic leukemia cells (Voss et al., 2007). Apoptosis was 
evaluated by analysing the percentage of hypodiploid nuclei by propidium iodide 
incorporation with the collaboration of  Dr. Alessandra Tosco, Dipartimento di 
Farmacia, Universita` di Salerno. 
U937 cells were incubated with different concentrations of HAA (50, 100, 
and 200 mM) and 200 mM of compound 16, after 24 hours cells were harvested 
and analyzed for apoptosis. 
Figure 6.4 shows an increasing ability of HAA to induce apoptosis. 
Compound 16 was used as negative control. 
 
 
Figure 6.3: Aggregation kinetics of reduced  
insulin (A) or CS at 43○C (B) determined by  
light scattering. The spontaneous aggregation  
of the proteins (♦) and the aggregation of the  
proteins in the presence of 0.150 mM  
Hsp27 (▲), 0.150 mM Hsp27 and 0.3 mM 
compound 1 (■), or 0.150 mM Hsp27 and  
0.3 mM compound 16 (●). 
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6.5 Apoptosis evaluation by analysis of caspase-3 activity 
 
High levels of Hsp27 seem to block apoptosis induced by chemotherapeutic 
drugs through the binding of caspase-3 prodomain, which provides a protection 
against the proteolytic cleavage necessary for caspase-3 activation (Figure 
6.5A). 
 
 
Figure 6.4: Apoptosis evaluation by analysis of hypodiploid nuclei 
percentage in U937 cells incubated with different concentrations of 
HAA and compound 16 
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Caspase-3 activity was measured by a fluorimetric assay based on the 
proteolytic cleavage of the 7
which yields a fluorescent product. U937 cells were treated with different 
concentrations of HAA for 24 h. 
activity measurements in cell lysates, demonstrating a concurring increase in the 
executioner caspase activation. 
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-amido-4-methylcoumarin (AMC)-derived substrate 
Figure 6.5B shows the results of the caspase
 
Figure 6.5: (A) Scheme of the 
Hsp27 protection from the 
proteolytic cleavage necessary for 
caspase-3 activation; (
evaluation by analysis of caspase
activity measurements by 
fluorimetric assays in U937 cells 
incubated with different 
concentrations of HAA.
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6.6 Conclusion 
 
Since the previous studies were aimed at the identification of the molecular 
target(s) of clerodane diterpenes this further investigation suggested that these 
compounds can interact with Hsp27, modulating its biological activity.  
Chemical proteomic approaches, used in this study resulted efficient and 
reliable, allowing us to identify the possible molecular target responsible for the 
observed effect of clerodane diterpenes on certain cancer cells proliferation and 
survey.  
The multidisciplinary approach used to validate the chemical proteomics 
results confirmed the affinity of these molecules towards the chaperone, also 
suggesting the protein region involved in the interaction, and permitted to 
demonstrate the inhibitory effects of such interaction on Hsp27 chaperon activity. 
At the cellular level, this inhibition resulted in a concentration dependent 
activation of caspase-3 determining the observed pro-apoptotic effect.  
Despite the increasing interest towards small heat shock proteins because of 
their emerging role in different physiological and pathological processes, few 
compounds capable of modulating their biological activity have been actually 
described.  
However, such molecules could represent a useful tool both to design new 
therapeutic agents and as probes to investigate the structure and function of these 
chaperones. In this light, HAA and related compounds could be promising in the 
development of optimized compounds. 
 
  
 
 
  
  
 
 
 
 
 
 
 
 
 
 
Experimental section 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7 
Phytochemical methods 
 
  
  
 
 
 
 
 
Phytochemical methods Chapter 7 
 
103 
 
 
Chapter 7 
 
7.1 Chromatography techniques 
 
7.1.1 Thin Layer Chromatography (TLC)  
 
TLC was performed on precoated kieselgel 60 F254 plates (Merck), 0.25 mm 
thick, with glass or aluminium as support. The spots were revealed using UV 
detection with lamp at 254 or 366 nm and successively using a specific spray 
reagent, allowing to the development of typical colouring that can give 
information about the nature of examined compounds. As eluting solvents in the 
TLC analyses, some mixtures of solvents were mainly used: CHCl3:MeOH 
(99:1), CHCl3:MeOH (98:2), CHCl3:MeOH (97:3), CHCl3:MeOH (95:5), 
CHCl3:MeOH (9:1), CHCl3:MeOH:H2O (40:9:1), CHCl3:MeOH:H2O (70:30:3), 
n-BuOH:AcOH:H2O (60:15:25). 
CeSO4/H2SO4, a general reactive, was used to reveal all compounds contained 
in mixtures. It is a saturated solution of cerium sulphate in 65% sulphuric acid. 
Heating at 120°C for 15 min is needed to reveal the spots. 
 
 
7.1.2 Column Chromatography (CC) 
 
7.1.2.1 Gel Filtration Chromatography 
 
Gel filtration chromatography was performed over Sephadex LH-20 (25-100 
µm, Pharmacia Fine Chemicals) using columns 3 x 100 cm, for 2-4 g of extract, 
  
and 5 x 100 cm for 5-10 g of material, and a peristaltic pump Pharmacia Fine 
Chemicals P1. The eluent was 
mL/min). 
 
7.1.2.2 Flash Chromatography
 
Flash chromatography (
410 µm, Merck), eluting with CHCl
Compressed air was used 
Columns size, related to the quantity of mixtures charged, are illustrated in 
7.1. 
 
 
Table 7.1: Flash chromatography parameter
Diameter 
(mm) 
Length
(mm)
10 160
20 160
30 160
40 160
100 160
 
 
 
 
 
 
 
 
Figure 7.1
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always methanol, at constant flow rate (0.8 
 
Figure 7.1) was performed over Silica gel 60 (230
3 containing an increasing amount of MeOH. 
maintaining a constant flow rate at 20 mL/min. 
Table 
 
 
 
Material 
(mg) 
 40-100 
 160-400 
 400-900 
 800-1600 
 5000 
: Flash chromatography column 
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Some purification were carried out with Biotage
purification system to improve fractions and compound purity with 
and PDA spectral analysis at 254 and 320 nm.
quantity of the mixture charged, is reported in 
 
Table 7.2:
Cartridge 
(g) 
10 
25 
50 
100 
340 
 
7.1.2.3 Solid Phase Extraction (SPE) Chromatography
 
SPE chromatography was conducted over silica gel 60 RP
Merck) using H2O containing an increasing amount of MeOH. Columns size, 
related to the quantity of mixtures charged, are illustrated in 
 
 
Figure 7.2:
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®
 Isolera® Spektra four flash 
λ detection 
 Cartridge size, related to the 
Table 7.2. 
 Biotage® Isolera®parameters 
Load capacity (mg) Flow rate 
 (ml/min) 
100-500 10-20 
250-1250 15-40 
500-2500 30-50 
1000-5000 30-50 
3400-17000 65-120 
 
-18 (40-63 µm, 
Figure 7.2. 
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7.1.2.4  High Performance Liquid Chromatography (HPLC)
 
Reverse-phase HPLC 
LC-8A series pumping system equipped with a Shimadzu RID
index detector and Shimadzu injector on a C
mm, 10 µm Waters, flow rate 2.0 ml/min). MeOH:H
mobile phases. 
 
 
 
7.1.2.5 Gas Chromatography (GC)
 
Gas chromatography analyses were performed using a Dani GC 1000 
instrument on a L-CP-Chirasil
 
7.2 Nuclear Magnetic Resonance 
 
NMR experiments were performed on Advance Bruker 250 spectrometer 
(Figure 7.5) and Bruker DRX
spectra were acquired in CD
with the transmitter set at the
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separations (Figure 7.3) were conducted on a Shimadzu 
-10A refractive 
18 µ-Bondapak column (30 cm x 7.8 
2O mixtures were used as 
Figure 7.3: HPLC system 
 
-Val column (0.32 mm x 25 m). 
analyses (NMR) 
-600 spectrometer at 300 K. All the 2D NMR 
3OD or in DMSO-d6 in the phase-sensitive mode 
 solvent resonance and TPPI (Time Proportional 
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Phase Increment) used to achieve frequency discrimination in the 
Standard pulse sequences and phase cycling were used for DQF
HSQC, HMBC, and ROESY experiments. NMR data were process
software and Silicon Graphic Indigo2 Workstation using UXNMR software.
Chemical shifts were expressed in 
peaks δH 3.34 and δC 49.0 for CD
 
 
Figure 7.4: 
 
 
7.3 Mass Spectrometry analyses (MS) 
 
MS and MSn analyses (positive and negative mode) were obtained using a 
LCQ Advantage spectrometer (Thermo Finnigan, San Jose, CA, USA) equipped 
with an ion trap analyzer and 
analyzed molecules were dissolved in MeOH and then diluted to 10
Samples were injected into the spectrometer at a flow rate of 5 µL/min using an 
external syringe pump. HRESIMS were achieved using a nano
system, with a nanoAcquity UPLC module and a Q
Phytochemical methods Chapter 7
ω1 dimension. 
-COSY, TOCSY, 
ed on Topsin 
δ (parts per million) referenced to the solvent 
3OD and δH 2.49 and δC 39.5 for DMSO-d6. 
 
Advance Bruker 250 NMR spectrometer 
 
Xcalibur 3.1 software (Figure 7.5). All the 
-20 µm/mL. 
 LC-MS/MS 
-TOF premiere spectrometer 
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equipped with a nanoelectrospray ion source (Waters
provided with a lock-mass apparatus to perform a real
correction.  
 
 
Figure 7.5:
7.4 Optical Rotations analyses
 
Optical rotations analyses were measured on a Perkin
equipped with a sodium lamp (589 nm) and a 1 dm microcell. 
 
7.5 Ultraviolet-Visible (UV) Spectroscopy
 
UV spectra were recorded on a Perkin
Sample were dissolved in MeOH.
 
7.6 Circular Dichroism (CD) Spectroscopy
 
CD spectra were measured on a JASCO J
cm cell in DMSO at room temperature under
nm/min, time constant 1 s, bandwidth 2.0 nm.
Phytochemical methods Chapter 7
-Milford, MA, USA), and 
-time calibration 
 
 LCQ Advantage ion trap mass spectrometer 
 
 
–Elmer 241 polarimeter 
 
 
–Elmer–Lambda Spectrophotometer. 
 
 
-810 spectropolarimeter with a 0.1 
 the following conditions: speed 50 
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7.7 Determination of absolute configuration of the 15,16-diol moiety using 
Snatzke’s method 
 
Dimolybdenum tetracetate was purchased from Sigma–Aldrich. According to 
the published procedure (Di Bari et al., 2001), about 1:1 diol-to-molybdenum 
mixtures were prepared using 0.5 mg/ml of each compound. Soon after mixing, 
the first CD spectrum was recorded and its evolution monitored until stationary 
(30–60 min). The sign of the diagnostic band at 305 nm is correlated to the 
absolute configuration of the 15,16-diol moiety. 
 
7.8 Acid hydrolysis  
 
A solution of each compound (2.0 mg) in 1 N HCl (1 ml) was stirred at 80 ○C 
in a stoppered reaction vial for 4 h. After cooling,the solution was evaporated 
under a stream of N2. The residue was dissolved in 1-(trimethylsilyl)imidazole 
and pyridine (0.2 ml), and the solution was stirred at 60 ○C for 5 min. After 
drying the solution, the residue was partitioned between H2O and CHCl3. The 
CHCl3 layer was analyzed by GC using a L-CP-Chirasil-Val column (0.32 mm x 
25 m). Temperatures of both the injector and detector was 200 ○C. A temperature 
gradient system was used for the oven, starting at 100 ○C for 1 min and 
increasing up to 180 ○C at a rate of 5 ○C/min. Peaks of the hydrolysate were 
detected by comparison with retention times of authentic samples of D-xylose, L-
arabinose, L-rhamnose, and D-glucose (Sigma–Aldrich) after treatment with 1-
(trimethylsilyl)imidazole in pyridine.  
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Chapter 8 
 
8.1 Material 
 
Epoxy-Activated Sepharose 6B® support and the protease inhibitor cocktail 
were purchased from Sigma Aldrich. Hsp 60, Hsp 70 and PPARγ were obtained 
from Tebu-Bio. HTC-116 cell line pellets were obtained on kind concession of 
Dr. S. De Falco, Istituto di Genetica Molecolare, CNR, Napoli. Biacore 3000, 
CM5 sensor chip, and coupling reagents [N-ethyl-N’-(3-dimethylaminopropyl) 
carbodiimide (EDC), N-hydroxy-succinimmide (NHS), and ethanolamine-HCl] 
were purchased from GE Healthcare (United Kingdom).  
 
8.2 Chemical immobilization of 15-ketoatractyligenin methyl ester  
 
The Epoxy-Activated Sepharose 6B® resin was treated as specified from the 
company before the use. 8.57 mg of the previously swelled resin was treated with 
1.1 mg of SR 2017, dissolved in 60% of CH3CN and 40% of 50 mM sodium 
bicarbonate (NaHCO3) at pH 8 for 24 h a 35 °C under continuous shaking. Final 
volume was 200 µl.  
The amount of immobilized SR2017 was calculated integrating the peaks 
relative to free SR2017 after HPLC injections of supernatants at t = 0 h and t = 
24 h. An Agilent 1100 Series chromatoghapher (Figure 8.1), binary pump (G-
1312A), autosampler (G1329A), DAD (G-1315D) was used on a C12 Jupiter 4µ 
PROTEO (150 x 2.00 mm) column at flow rate of 0.3 ml/min. The gradient 
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(solution A: H2O 1% HCOOH, solution B: CH3CN) started at 30% and ended at 
95% B after 25 min (Table 8.1). 
 
 
Figure 8.1: HPLC-DAD Agilent 
 
Table 8.1: HPLC gradient used to quantify SR2017 immobilization yield 
Time  % B 
0 30 
5 30 
20 60 
21 70 
23 95 
25 95 
 
 
The residual epoxy groups were blocked by consecutive washing steps with 
50 mM NaHCO3 pH 8 and the final addition of 50 µl of 1 M ethanolamine at pH 
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8 for 16 h at 45 °C. The ethanolamine exceeding was removed with consecutive 
and alternate washing steps 0.1 M CH3COONa (sodium acetate), 0.5 M Sodium 
chloride (NaCl) at pH 4 and 0.1 M tris(hydroxymethyl)aminomethane 
hydrochloride (Tris HCl), 0.5 M NaCl at pH 8. PBS was used for a final washing. 
The same procedure was used to obtain the control matrix.  
 
8.3 Purification of Proteic SR2017 Targets by Affinity Chromatography 
 
Cell pellets were lysed in PBS 1X (50 mM sodium Phosphate, 150 mM 
NaCl), 0.1% Igepal. Protease inhibitor cocktail was added and the mixture was 
stored in ice for 30 min and then clarified by centrifugation 12000 g, 4 °C for 15 
min. Protein concentration was determined by Bradford assay (Bradford, 1976; 
Van Kley and Hale, 1977) and adjusted to 1 mg/ml. 
SR2017-fixed beads (50 µl dry volume) and the control beads (50 µl dry 
volume) were separately mixed with 500 µl of crude cell extract (1 mg/ml) and 
incubated at 4 ○C for 16 h on a rotating wheel. After three washing with PBS 1% 
glycerol and two with PBS, the bound proteins were eluted with SDS-PAGE 
sample buffer (60 mM Tris HCl pH 6.8, 2% SDS, 0.001% bromophenol blue, 
10% glicerol, 2% 2-mercaptoethanol). 
Eluted samples were loaded on a monodimensional 12% SDS-PAGE, and 
separated proteins were stained with Brilliant Blue G-Colloidal (Sigma Aldrich). 
In gel trypsin digestions were performed as described (Shevchenko et al., 2006). 
Briefly, Coomassie-stained protein bands were excised from the polyacrylamide 
gel, reduced, alkylated using iodoacetamide, and digested by trypsin. The 
resulting fragments were extracted and analyzed by LC/MS/MS using a Q-TOF 
premier instrument (Figure 8.2) (Waters, Milford, USA) equipped with a nano-
ESI source coupled with a nano-Acquity capillary UPLC (Waters): peptide 
separation was performed on a capillary BEH C18 column (0.075 mm x 100 mm, 
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1.7 mm, Waters) using aqueous 0.1% HCOOH (A) and CH3CN containing 0.1% 
HCOOH (B) as mobile phases. Peptides were eluted by means of linear gradient 
from 5% to 50% of B in 45 min and a 300 nL/min flow rate. Capillary ion source 
voltage was set at 2.5 kV, cone voltage at 35 V, and extractor voltage at 3 V. 
 
 
 
Figure 8.2: Q-TOF instrument 
 
 
Peptide fragmentation was achieved using argon as collision gas and a 
collision cell energy of 25 eV. Mass spectra were acquired in an m/z range from 
400 to 1800, and MS/MS spectra in a 25–2000 range. Mass and MS/MS spectra 
calibration was performed using a mixture of angiotensin and insulin as an 
external standard and [Glu]-Fibrinopeptide B human as a lock mass standard. 
A gel-free approach was also used: proteins were eluted from the resin using 
guanidine hydrochloride 6 M, dithiothreitol 20 mM, Tris–HCl 50 mM solution, 
pH 7.8. After a 30 min incubation with iodoacetamide, the protein mixtures 
underwent trypsin digestion. Resulting peptides were analyzed by the previously 
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described LC/MS/MS apparatus, using for the chromatographic separation a 
linear gradient from 3% to 55% of B in 90 min. MS and MS/MS conditions were 
identical to those described above. In both experiments, doubly and triply 
charged peptide-ions were automatically chosen by the MassLynx software and 
fragmented. MS data were automatically processed and peaklists for protein 
identifications by database searches were generated by the ProteinLynx software. 
MS and MS/MS data were used by Mascot (Matrix Science) to interrogate the 
Swiss Prot non-redundant protein database. Settings were as follows: mass 
accuracy window for parent ion, 50 ppm; mass accuracy window for fragment 
ions, 200 millimass units; fixed modification, carbamidomethylation of cysteines; 
variable modifications, oxidation of methionine. Proteins with more than 2 
peptides and program scores >75 were considered as reliable proteins. Protein 
Prospector software was eventually used to confirm protein identification; setting 
parameters included selection of trypsin with up to 2 missed cleavage sites, fixed 
modification, carbamidomethylation of cysteines; variable modifications, 
oxidation of methionine. 
 
8.4 Surface Plasmon Resonance (SPR)  
 
To perform SPR studies optical biosensor BIACORE 3000 (GE Healthcare) 
was used. Hsp 60 and Hsp 70 solutions 1 µM in 50 mM sodium acetate at pH 4 
were prepared. Human recombinant PPARγ solution 1 µM in sodium acetate 100 
mM at pH 4.5 was prepared. Each protein was separately immobilized on a CM5 
sensor chip (Figure 3). The carboxylic groups of the chip were previously 
activated by EDC 0.2 M and NHS 0.05 M. The exceeding active groups were 
inactivated with ethanolamine 1 M. SR2017 was dissolved in 100% DMSO to 
obtain a 4 mM solution, and then diluted 1:1000 (v/v) in PBS (10 mM NaH2PO4, 
150 mM NaCl, pH 7.4) to a final DMSO concentration of 0.1%. For PPARγ it 
Chemical proteomics applied to 15
 
 
 
was used HBS-EP buffer instead of PBS. HBS is made up of 0.01 M 
hydroxyethyl)piperazine-
mM ethylenediaminetetraacetic acid (EDTA
concentration series of SR2017 was prepared as twofold dilutions into running 
buffer: the complete binding study was performed using a six
series, typically spanning 0.025
concentration were dispensed into single
Multiple blank samples of running buffer alone were included in each 
analysis. Binding experiments were performed at 25 
mL min-1. The dissociation time was set at 600 seconds. Rate constants 
association (ka) dissociation (kd) and the dissociation constant (KD) were 
obtained by globally fitting data from all the injection of different concentration 
of the sample, using the simple 1:1 Langmuir binding model. Simple interactions 
were adequately fit to a single
yielding a single KD. Sensorgram elaborations were performed using the 
BIAevaluation software provided by GE Healthcare. The procedure was repeated 
for each SR2017 injection series on each
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4
1-ethanesulfonic acid (HEPES) pH 7.4, 0.15 M NaCl, 3 
) and Surfactant P20 0.005%. A
-point concentration 
–1 mM, and triplicate aliquots of the sample’s 
-use vials.  
○C, using a flow rate of 50 
-site bimolecular interaction model (A + B = AB), 
 immobilized protein. 
  
Figure 8.3: Sensor chip CM5 
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Chapter 9 
 
9.1 HAA/Hsp27 interaction: limited proteolysis 
 
Limited proteolysis experiments were performed at 37 °C in PBS, 0.1% 
DMSO, and 20 mM DTT, using trypsin, endoproteinase GluC (V8) or 
chymotrypsin as proteolytic agents; 30 mL of a 2 mM Hsp27 solution were used 
for each experiment. Binary complex Hsp27/hardwickiic acid was formed by 
incubating the protein with a 5:1 molar excess of the compound at 37 ○C for 15 
min prior to proteolytic enzyme addition. Both protein and the complex were 
digested using a 1:100 (w/w) enzyme to substrate ratio. The extent of the 
reactions was monitored on a time-course basis by sampling the incubation 
mixture after 5, 15, and 30 min of digestion. Samples were desalted by ziptip C4 
(Merk Millipore) and the proteolytic fragments were analyzed by 
MALDITOF/MS (Figure 9.1) using a MALDI micro MX (Waters). In order to 
optimize the sensitivity and accuracy of the mass measurements, two different 
m/z ranges were explored for each sample: a first range, from m/z 500 to 3500 
was analyzed in reflector mode; the other range, from m/z 3500 to 25000 was 
analyzed in linear mode. Each m/z range was calibrated using a suitable peptide 
or protein mixture. Mass data were elaborated using the Masslynx software 
(Waters). Preferential hydrolysis sites on Hsp27 under different conditions were 
identified on the basis of the fragments released during the enzymatic digestions. 
When comparative experiments were carried out on Hsp27 in the presence or 
absence of HAA, differences in the susceptibility of specific cleavage sites were 
detected, from which protein regions involved in the conformational changes 
could be inferred.  
  
 
 
9.2 Insulin and citrate synthase (CS) aggregation assays
 
The ability of HAA to modulate the chaperone activity of Hsp27 was 
evaluated by monitoring the insulin DTT induced and the citrate synthase (CS) 
thermal induced aggregation in the presence of stoichiometric amounts of Hsp27, 
and with or without a 4-fold molar excess of HAA. The aggregation process was 
monitored by right angle light scatter
50B fluorimeter with a Perkin Elmer PTP
thermostated quartz cells. Both the emission and excitation wavelengths were set 
at 500 nm, and the band pass was 5 nm. Kinetics traces
averages of two measurements. Insulin aggregation was initiated incubating 0.57 
nmol of the polypeptide with 0.1 M DTT in PBS, pH 7.4 at 37 
aggregation was initiated by submitting the protein (0.075 mM) to an incubation 
in 40 mM HEPES–KOH, pH 7.5 at 43 °C. To eliminate the exceeding citrate 
before the analyses, CS was dialyzed against Tris
mM, at pH 8 using a 500 mL cut
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Figure 9.1: MALDI-TOF instrument 
 
ing measurements, using a Perkin Elmer LS 
-1 controlled water bath in stirred and 
 reported here are the 
○C. CS 
–HCl, 50 mM, and EDTA, 2 
-off 10 000 Da filter. 
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9.3 Apoptosis evaluation  
 
U937 cells were seeded in 48-well plastic plates, 250 mL per well at 2 x 105 
cells mL-1 and HAA or compound 16 was added at different concentrations (50, 
100 and 200 mM) for 24 h. At the end of the treatments 250 mL of a hypotonic 
buffer (0.1% sodium citrate, 0.1% Triton X-100 and 50 mg mL-1 propidium 
iodide) was added to cell suspensions. Apoptosis was evaluated by analysing the 
percentage of hypodiploid nuclei by propidium iodide incorporation. Samples 
were analysed by a FACS-Calibur flow cytometer using the Cell Quest software 
(Becton Dickinson, North Ryde, NSW, Australia). All the experiments were 
performed at least in triplicate. 
 
9.4 Analysis of caspase-3 activity  
 
Caspase-3 activity was measured by a fluorimetric assay based on the 
proteolytic cleavage of the 7-amido-4-methylcoumarin (AMC)-derived substrate 
(Ac-DEVD-AMC, Sigma-Aldrich), which yields a fluorescent product. U937 
cells were treated with different concentrations of HAA for 24 h, then harvested 
and washed three times with PBS 1X. Pellets were lysed with caspase-3 reaction 
buffer (50 mM HEPES pH 7.5, 0.1 mM EDTA, 0.1% Nonidet P-40, 0.1% 
CHAPS, 1 mM DTT) incubated for 30 min on ice and clarified by centrifugation 
for 15 min at 15000 g at 4 oC. Assays were performed in 96-well plates by 
incubating 10 mg of protein extracts with 20 mM Ac-DEVD-AMC in 200 mL of 
assay buffer at 37 oC for 3 h. Samples were analyzed using a micro-plate reader 
(L55 Fluorescence Spectrometer Perkin Elmer Instruments; excitation: 360 nm, 
emission: 460 nm). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 10 
Conclusions 
 
 
 
 
 
 
  
  
 
 
 
  
Conclusions 
 
This thesis work reported an approach to
diterpenoids isolated from natural source
application (Figure 10.1).
 
 
 
 
 
The starting point was the
diterpenes: Podocarpus 
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 investigate the activities of 
 in order to find for them an interesting 
 
Figure 10.1: Work scheme 
 selection of some plants known as rich in 
elongatus, Podocarpus gracilior, Clerodendrum 
 
119 
 
Conclusions Chapter 10 
 
120 
 
splendens, and Sideritis pullulans. The following step was their phytochemical 
study with the aim to isolate pure compounds. Chromatographic separation led to 
the isolation and structural characterization of 27 diterpenes of which 18 were 
new natural compounds (Figure 10.2-10.7). These compounds were introducted 
in our diterpenes library (Chapters 2-4). 
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Figure 10.2: New diterpenes isolated from Podocarpus spp., see Chapter 2 
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Figure 10.3: Structures of known diterpenes from Podocarpus spp., see Chapter 2 
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Figure 10.4: New clerodanes from C. splendens, see Chapter 3 
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Figure 10.5: Known clerodanes from C. splendens, see Chapter 3 
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Figure 10.6: New diterpenes from S. pullulans, see Chapter 4 
 
 
HO
CH2OH
OH
10
CH2OH
O
HO OH
OCOCH3
9 HO OH
OCOCH3
13
 
 
Figure 10.7: Known diterpenes from S. pullulans, see Chapter 4 
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The importance of natural compounds libraries was described in Chapter 1 
and in Chapter 5 a method for the research of the molecular targets for small 
molecules library was described: the fishing for partners study. Using this 
chemical proteomics approach, Hsp70 and PPARγ were recognized as potential 
proteic targets for the semi-synthetic derivative of atractyligenin, 15-
ketoatractyligenin methyl ester, an ent-kaurane selected from our library. The 
power of the chemical proteomics was clear in this investigation since it could be 
applied when the information about the proteic targets are lacking. The targets of 
bioactive molecules are often unknown even if the biological effects are quite 
known like in our case. Further studies will be necessary to validate these two 
targets and also to explain the relationships between the interactions of the 
atractyligenin derivative and the two proteins and the effects that were observed 
in cancer cell lines. 
In Chapter 6 some methods to validate Hsp27 as molecular target for HAA 
were reported. HAA induced a conformational change in N-terminal domain of 
the protein and enhanced the chaperone function. Very few information about 
ligand of the small heat shock proteins are available and HAA together with the 
other clerodanes of our library could be a useful tool both to design new 
therapeutic agents and as probes to investigate the structure and function of these 
chaperones.
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